<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003008.pub3" GROUP_ID="BACK" ID="122500073113404196" MERGED_FROM="" MODIFIED="2013-04-30 15:23:24 +0100" MODIFIED_BY="Teresa Marin" REVIEW_NO="" REVMAN_SUB_VERSION="5.2.3 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="11.0">
<COVER_SHEET MODIFIED="2013-04-30 10:14:08 -0400" MODIFIED_BY="Teresa Marin">
<TITLE MODIFIED="2008-07-07 18:22:34 -0400" MODIFIED_BY="[Empty name]">Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low-back pain</TITLE>
<CONTACT>
<PERSON ID="9058" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Lucie</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Brosseau</LAST_NAME>
<SUFFIX/>
<POSITION>Assistant Professor</POSITION>
<EMAIL_1>Lucie.Brosseau@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Rehabilitation Sciences, Faculty of Health Sciences</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>451 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H 8M5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613-562-5800 ext: 8015</PHONE_1>
<PHONE_2/>
<FAX_1>+1 613-562-5428</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2013-04-30 10:02:03 -0400" MODIFIED_BY="Teresa Marin">
<PERSON ID="303D48C982E26AA2010AB3F27E1D34F8" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Amole</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Khadilkar</LAST_NAME>
<SUFFIX/>
<POSITION>student</POSITION>
<EMAIL_1>amolek@rogers.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Rehabilitation Sciences</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>89 Stonehurst Avenue</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>J4Y-1V3</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>613-562-5800 ext 8015</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="7EAD864082E26AA20029B8545220C634" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Daniel Oluwafemi</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Odebiyi</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Lecturer</POSITION>
<EMAIL_1>femiodebiyi@yahoo.com</EMAIL_1>
<EMAIL_2>dodebiyi@unilag.edu.ng</EMAIL_2>
<URL/>
<MOBILE_PHONE>+23480 2471 7968</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>Department of Physiotherapy, Faculty of Clinical Sciences</DEPARTMENT>
<ORGANISATION>College of Medicine, University of Lagos, Lagos</ORGANISATION>
<ADDRESS_1>PMB 12003, Idi-araba, Surulere</ADDRESS_1>
<ADDRESS_2/>
<CITY>Lagos</CITY>
<ZIP>101014</ZIP>
<REGION>Lagos</REGION>
<COUNTRY CODE="NG">Nigeria</COUNTRY>
<PHONE_1>080-247-17968</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="9058" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Lucie</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Brosseau</LAST_NAME>
<SUFFIX/>
<POSITION>Assistant Professor</POSITION>
<EMAIL_1>Lucie.Brosseau@uottawa.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>School of Rehabilitation Sciences, Faculty of Health Sciences</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>451 Smyth Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>Ottawa</CITY>
<ZIP>K1H 8M5</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613-562-5800 ext: 8015</PHONE_1>
<PHONE_2/>
<FAX_1>+1 613-562-5428</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12662" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>George</FIRST_NAME>
<MIDDLE_INITIALS>A</MIDDLE_INITIALS>
<LAST_NAME>Wells</LAST_NAME>
<SUFFIX>PhD, MSc</SUFFIX>
<POSITION>Director, Cardiovascular Research Methods Centre</POSITION>
<EMAIL_1>gawells@ottawaheart.ca</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Epidemiology and Community Medicine</DEPARTMENT>
<ORGANISATION>University of Ottawa</ORGANISATION>
<ADDRESS_1>Room H1-1</ADDRESS_1>
<ADDRESS_2>40 Ruskin Street</ADDRESS_2>
<CITY>Ottawa</CITY>
<ZIP>K1Y 4W7</ZIP>
<REGION>Ontario</REGION>
<COUNTRY CODE="CA">Canada</COUNTRY>
<PHONE_1>+1 613 798 5555 x18640</PHONE_1>
<PHONE_2>+1 613 798 5555 x18642</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2009-11-23 10:54:01 -0500" MODIFIED_BY="Victoria Pennick">
<UP_TO_DATE>
<DATE DAY="19" MONTH="7" YEAR="2007"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="19" MONTH="7" YEAR="2007"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="1" MONTH="6" YEAR="2010"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="1998"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2008"/>
</DATES>
<WHATS_NEW MODIFIED="2013-04-30 10:14:08 -0400" MODIFIED_BY="Victoria Pennick">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-04-30 10:14:08 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="30" MONTH="4" YEAR="2013"/>
<DESCRIPTION>
<P>This review is currently being updated by a new review team. This new version of the review will include an expanded set of comparisons, such that TENS will be compared to placebo as well as other active treatments. See Published Notes for additional information.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-11-23 10:54:01 -0500" MODIFIED_BY="Victoria Pennick">
<DATE DAY="23" MONTH="11" YEAR="2009"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2009-11-23 10:54:01 -0500" MODIFIED_BY="Victoria Pennick">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-11-23 10:54:01 -0500" MODIFIED_BY="Victoria Pennick">
<DATE DAY="6" MONTH="6" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2009-11-23 10:54:01 -0500" MODIFIED_BY="Victoria Pennick">
<DATE DAY="2" MONTH="6" YEAR="2008"/>
<DESCRIPTION>
<P>Two additional trials were included (Jarzem 2005, Topuz 2004). In addition, an abstract by Cheing et al., 1996 was identified in the conference proceedings of the 8th World Congress of Pain. This abstract was based on the same trial as a previously included journal article (Cheing, 1999), but the outcomes were reported after a longer treatment period. Additional data were obtained from the authors of this study to facilitate analysis.<BR/>
<BR/>An ongoing trial to be completed by October 2008 awaits review.<BR/>
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-11-23 10:54:01 -0500" MODIFIED_BY="Victoria Pennick">
<DATE DAY="19" MONTH="7" YEAR="2007"/>
<DESCRIPTION>
<P>For this 2nd update, a revised search strategy was conducted between 2004 and 2007. The CINAHL database was added to the search.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="FEEDBACK" MODIFIED="2008-06-06 10:51:59 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="8" YEAR="2005"/>
<DESCRIPTION>
<P>Feedback on Khadilkar 2005 updated review</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-06-06 10:44:41 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="30" MONTH="4" YEAR="2005"/>
<DESCRIPTION>
<P>The current systematic review represents a substantial update and revision of the original Cochrane Review published in 2001.<BR/>
<BR/>The search strategy used in original review was re-executed from 2000 to April 2005. In an effort to retrieve any potentially relevant studies missed in the original review, we also ran a parallel search of MEDLINE, using a modified search strategy from 1966 to April 2005. One article (Cheing 1999) met the eligibility criteria and was included in this update.<BR/>
<BR/>We modified the inclusion criteria to examine a more homogeneous chronic LBP population. Based on the new criteria, four of the five trials included in the original review were excluded (Gemignani 1991, Jarzem 1997, Marchand 1990, Moore 1997).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="FEEDBACK" MODIFIED="2008-06-06 10:52:04 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="2" YEAR="2005"/>
<DESCRIPTION>
<P>Feedback on Milne 2001 added</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>CIGNA Foundation provided an educational grant</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Lucie Brosseau is an Ontario Ministry of Health Career Scientist</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-03-31 12:14:05 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2008-08-13 09:10:39 -0400" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-07-30 09:57:46 -0400" MODIFIED_BY="[Empty name]">Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low-back pain</TITLE>
<SUMMARY_BODY MODIFIED="2008-08-13 09:10:39 -0400" MODIFIED_BY="[Empty name]">
<P>Low-back pain (LBP) represents a leading cause for work absenteeism and visits to health care professionals. Sixty to 90% of the adult population is at risk of developing LBP. While the majority of episodes appear to resolve within six weeks, recurrences are common. In addition, it is estimated that 10% to 20% of affected adults develop symptoms of chronic LBP (persistent pain lasting longer than three months). Chronic LBP has a significant impact on everyday life.</P>
<P>Transcutaneous electrical nerve stimulation (TENS) is widely used as a supplemental therapy in the management of LBP.  It is a relatively safe, non-invasive and easy to use treatment option. TENS units deliver electrical stimulation to the underlying nerves via electrodes placed over the intact skin surface near the source of maximal pain.</P>
<P>Four high-quality randomized controlled trials (RCTs; 585 patients) comparing TENS with placebo for chronic low-back pain were included in this study.  Due to conflicting evidence, it is unclear if TENS is beneficial in reducing back pain intensity.  However, there was consistent evidence in two trials (410 patients) that TENS did not improve the level of disability due to back pain. There was moderate evidence that use of medical services and work status (e.g. loss of work, sick days) did not change during treatment. Finally, there did not seem to be a difference between conventional and acupuncture-like TENS. </P>
<P>Some adverse effects were reported, typically minor skin irritations observed equally in the treatment and placebo groups. However, there was one participant who developed a severe rash four days after the start of treatment. </P>
<P>In summary, the review authors found conflicting evidence regarding the benefits of TENS for chronic LBP, which does not support the use of TENS in the routine management of chronic LBP. </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-08-11 14:15:26 -0400" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2008-08-08 11:59:03 -0400" MODIFIED_BY="[Empty name]">
<P>Transcutaneous electrical nerve stimulation (TENS) was introduced more than 30 years ago as a therapeutic adjunct to the pharmacological management of pain. However, despite widespread use, its effectiveness in chronic low-back pain (LBP) is still controversial.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2008-07-29 14:31:10 -0400" MODIFIED_BY="[Empty name]">
<P>To determine whether TENS is more effective than placebo for the management of chronic LBP.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-07-29 14:31:25 -0400" MODIFIED_BY="[Empty name]">
<P>The Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, PEDro and CINAHL were searched up to July 19, 2007.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Only randomized controlled clinical trials (RCTs) comparing TENS to placebo in patients with chronic LBP were included. </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-08-11 11:48:30 -0400" MODIFIED_BY="[Empty name]">
<P>Two review authors independently selected the trials, assessed their methodological quality and extracted relevant data. If quantitative meta-analysis was not possible, a qualitative synthesis was performed, taking into consideration 5 levels of evidence as recommended by the Cochrane Collaboration Back Review Group.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-08-11 14:15:26 -0400" MODIFIED_BY="[Empty name]">
<P>Four high-quality RCTs (585 patients) met the selection criteria. Clinical heterogeneity prevented the use of meta-analysis. Therefore, a qualitative synthesis was completed. There was conflicting evidence about whether TENS was beneficial in reducing back pain intensity and consistent evidence in two trials (410 patients) that it did not improve back-specific functional status. There was moderate evidence that work status and the use of medical services did not change with treatment. Conflicting results were obtained from two studies regarding generic health status, with one study showing no improvement on the modified Sickness Impact Profile and another study showing significant improvements on several, but not all subsections of the SF-36 questionnaire. Multiple physical outcome measures lacked statistically significant improvement relative to placebo. In general, patients treated with acupuncture-like TENS responded similarly to those treated with conventional TENS. However, in two of the trials, an inadequate stimulation intensity was used for acupuncture-like TENS, given that muscle twitching was not induced. Optimal treatment schedules could not be reliably determined based on the available data. Adverse effects included minor skin irritation at the site of electrode placement.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2008-08-11 12:21:20 -0400" MODIFIED_BY="[Empty name]">
<P>At this time, the evidence from the small number of placebo-controlled trials does not support the use of TENS in the routine management of chronic LBP. Further research is encouraged.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2008-08-11 11:54:51 -0400" MODIFIED_BY="[Empty name]">
<P>Low-back pain (LBP) represents a leading cause for work absenteeism and visits to healthcare professionals (<LINK REF="REF-Andersson-1999" TYPE="REFERENCE">Andersson 1999</LINK>; <LINK REF="REF-Deveraux-2004" TYPE="REFERENCE">Deveraux 2004</LINK>). Sixty to 90% of the adult population is at risk of developing LBP at some point in their lifetime (<LINK REF="REF-Andersson-1997" TYPE="REFERENCE">Andersson 1997</LINK>; <LINK REF="REF-Andersson-1999" TYPE="REFERENCE">Andersson 1999</LINK>; <LINK REF="REF-Coste-1989" TYPE="REFERENCE">Coste 1989</LINK>; <LINK REF="REF-Deveraux-2004" TYPE="REFERENCE">Deveraux 2004</LINK>; <LINK REF="REF-Deyo-2006" TYPE="REFERENCE">Deyo 2006</LINK>; <LINK REF="REF-Deyo-1987a" TYPE="REFERENCE">Deyo 1987a</LINK>; <LINK REF="REF-Sierpina-2002" TYPE="REFERENCE">Sierpina 2002</LINK>; <LINK REF="REF-Skovron-1992" TYPE="REFERENCE">Skovron 1992</LINK>; <LINK REF="REF-Smeal-2004" TYPE="REFERENCE">Smeal 2004</LINK>). While the majority of episodes appear to resolve within six weeks, recurrences are common (<LINK REF="REF-Andersson-1999" TYPE="REFERENCE">Andersson 1999</LINK>; <LINK REF="REF-Pengel-2003" TYPE="REFERENCE">Pengel 2003</LINK>; <LINK REF="REF-Von-Korff-1996" TYPE="REFERENCE">Von Korff 1996</LINK>). In addition, it is estimated that 10% to 20% of affected adults develop symptoms of chronic LBP, defined as persistent pain occurring on most days and lasting longer than three consecutive months (<LINK REF="REF-Hildebrandt-2004" TYPE="REFERENCE">Hildebrandt 2004</LINK>; <LINK REF="REF-Maher-2004" TYPE="REFERENCE">Maher 2004</LINK>; <LINK REF="REF-Von-Korff-1996" TYPE="REFERENCE">Von Korff 1996</LINK>; <LINK REF="REF-Waddell--1998" TYPE="REFERENCE">Waddell 1998</LINK>). Chronic LBP has a significant impact on functional status, restricting occupational activities with marked socio-economic repercussions (<LINK REF="REF-Deyo-1987b" TYPE="REFERENCE">Deyo 1987b</LINK>; <LINK REF="REF-Van-Tulder-1999" TYPE="REFERENCE">Van Tulder 1999</LINK>).</P>
<P>The management of LBP encompasses a diverse range of possible interventions including drug therapy, surgery, exercise, patient education, physiotherapy, cognitive-behavioural therapy and various other non-pharmacological therapies. A multidisciplinary approach founded on the biopsychosocial model has been advocated for some patients (<LINK REF="REF-Deyo-2001" TYPE="REFERENCE">Deyo 2001</LINK>; <LINK REF="REF-Hildebrandt-2004" TYPE="REFERENCE">Hildebrandt 2004</LINK>; <LINK REF="REF-Maher-2004" TYPE="REFERENCE">Maher 2004</LINK>; <LINK REF="REF-Sierpina-2002" TYPE="REFERENCE">Sierpina 2002</LINK>). The goals of treatment are to relieve pain, reduce muscle spasm, increase strength and range of motion, promote an early return to activity and improve overall functional status. The risks and benefits of these treatments vary (<LINK REF="REF-Delitto-1993" TYPE="REFERENCE">Delitto 1993</LINK>; <LINK REF="REF-Ottenbacher-1995" TYPE="REFERENCE">Ottenbacher 1995</LINK>; <LINK REF="REF-Schlapbach-1991" TYPE="REFERENCE">Schlapbach 1991</LINK>). Acute and chronic LBP warrant separate consideration as they may respond differently to the same interventions (<LINK REF="REF-Sierpina-2002" TYPE="REFERENCE">Sierpina 2002</LINK>; <LINK REF="REF-Van-Tulder-1999" TYPE="REFERENCE">Van Tulder 1999</LINK>).</P>
<P>Transcutaneous electrical nerve stimulation (TENS) is widely used as a therapeutic adjunct in the management of LBP. It is a relatively safe, non-invasive and easy to use modality that can be conveniently self-administered by patients at home, making it an attractive treatment option. TENS units deliver electrical stimulation to the underlying peripheral nerves via electrodes placed over the intact skin surface, near the source of maximal pain (<LINK REF="REF-APTA-1993" TYPE="REFERENCE">APTA 1993</LINK>; <LINK REF="REF-Barr-1999" TYPE="REFERENCE">Barr 1999</LINK>; <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>; <LINK REF="REF-Sluka-2003" TYPE="REFERENCE">Sluka 2003</LINK>). The development and application of TENS was based on the <I>Gate Control Theory,</I> conceptualized by Melzack and Wall (<LINK REF="REF-Melzack-1982" TYPE="REFERENCE">Melzack 1982</LINK>). According to this theory, the stimulation of large diameter (A-beta), primary sensory afferents activates inhibitory interneurons in the substantia gelatinosa of the spinal cord dorsal horn and, thereby, blocks the transmission of nociceptive signals from small diameter A-delta and C fibres (<LINK REF="REF-Melzack-1965" TYPE="REFERENCE">Melzack 1965</LINK>; <LINK REF="REF-Melzack-1982" TYPE="REFERENCE">Melzack 1982</LINK>). Supraspinal mechanisms involving the endogenous opioid system have also been described (<LINK REF="REF-Han-1991" TYPE="REFERENCE">Han 1991</LINK>; <LINK REF="REF-Hughes-1984" TYPE="REFERENCE">Hughes 1984</LINK>; <LINK REF="REF-Kalra-2001" TYPE="REFERENCE">Kalra 2001</LINK>; <LINK REF="REF-Salar-1981" TYPE="REFERENCE">Salar 1981</LINK>). Overall, TENS is postulated to "close the gate" and dampen the perception of pain (<LINK REF="REF-Melzack-1982" TYPE="REFERENCE">Melzack 1982</LINK>).</P>
<P>Several types of TENS applications, differing in frequency, amplitude, pulse width and waveform, are used in clinical practice. The two most common application modes include: 1) high frequency or conventional TENS (frequency greater than 80Hz, pulse width less than 150 &#956;sec, low intensity sufficient to produce a comfortable tingling sensation) and 2) low frequency or so called acupuncture-like TENS (frequency less than 10Hz, pulse width greater than 150 &#956;sec, high intensity sufficient to elicit muscle twitching) (<LINK REF="REF-Belanger-2002" TYPE="REFERENCE">Belanger 2002</LINK>). Acupuncture-like TENS is associated with a slower onset and longer duration of analgesia compared to conventional TENS (<LINK REF="REF-Belanger-2002" TYPE="REFERENCE">Belanger 2002</LINK>). However, whether there is a significant difference in clinical effectiveness between high frequency and low frequency modes is unclear and not well defined (<LINK REF="REF-Belanger-2002" TYPE="REFERENCE">Belanger 2002</LINK>; <LINK REF="REF-Johnson-1991a" TYPE="REFERENCE">Johnson 1991a</LINK>). Indeed, patient preference for, and response to, different stimulation settings may be highly individualized (<LINK REF="REF-Johnson-1991a" TYPE="REFERENCE">Johnson 1991a</LINK>; <LINK REF="REF-Johnson-1991b" TYPE="REFERENCE">Johnson 1991b</LINK>; <LINK REF="REF-Tulgar-1991" TYPE="REFERENCE">Tulgar 1991</LINK>). Three other standard modes of TENS include: 1) Brief-Intense TENS (frequency greater than 80Hz, pulse width greater than 150 &#956;sec, brief duration of stimulation, very high intensity sufficient to activate nociceptive fibres in addition to motor fibres and primary sensory afferents), 2) Burst TENS (bursts of high frequency pulses delivered at low frequency (less than 10 Hz) and at a high enough intensity sufficient to activate both motor fibres and primary sensory afferents) and 3) Modulation TENS (one or more parameters are randomly modulated during therapy). Adverse reactions reported with TENS include skin irritation at the site of electrode placement (<LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>; <LINK REF="REF-Rushton-2002" TYPE="REFERENCE">Rushton 2002</LINK>). TENS is contraindicated in patients with cardiac pacemakers due to the potential for interfering with pacemaker activity (<LINK REF="REF-Belanger-2002" TYPE="REFERENCE">Belanger 2002</LINK>; <LINK REF="REF-Rushton-2002" TYPE="REFERENCE">Rushton 2002</LINK>).</P>
<P>The clinical benefit of TENS for chronic LBP is uncertain. The aim of this update was to re-evaluate its effectiveness relative to placebo.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-07-14 10:30:42 -0400" MODIFIED_BY="[Empty name]">
<P>To determine the effectiveness of TENS versus placebo for the management of chronic LBP.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-08-13 09:09:35 -0400" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2008-08-11 13:19:21 -0400" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2008-08-11 13:19:21 -0400" MODIFIED_BY="[Empty name]">
<P>Only RCTs with more than five LBP patients per treatment group were eligible. This sample size limit was applied based on the consensus opinion of the Philadelphia Panel (<LINK REF="REF-Philadelphia-Panel-2001" TYPE="REFERENCE">Philadelphia Panel 2001</LINK>).<BR/>
</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-08-11 11:55:04 -0400" MODIFIED_BY="[Empty name]">
<P>Outpatients, aged 18 years and over with chronic LBP were considered for this review. Chronic was defined as persistent pain (lasting longer than 12 weeks) localized between the inferior gluteal fold and the costal margin in the absence of malignancy, infection, fracture, inflammatory disorder or neurological syndrome. Subjects with symptoms and signs of sciatica or a previous history of back surgery were not specifically excluded from analysis, but had to represent a minority of the study sample to qualify for study selection (the latter criterion was newly defined for the current update in response to reader feedback and to enable generalizability of the results). Trials were excluded if they reported on subjects with a mix of chronic LBP and acute LBP (lasting less than six weeks) or subacute LBP (lasting six to12 weeks), unless the data were presented separately for chronic LBP. Similarly, trials investigating a study population with a mix of LBP and middle or upper back pain were also excluded.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-07-07 19:20:40 -0400" MODIFIED_BY="[Empty name]">
<P>All standard modes of TENS were considered for this review. Articles were excluded if either the experimental or control groups received electrical stimulation percutaneously using acupuncture needles. We only accepted placebo TENS for the control group, which generally consisted of a TENS device modified so that no electrical current passed to the skin surface electrodes. The use of co-interventions assigned equally to both the experimental and control groups was permitted. However, head-to-head comparisons of TENS with other active treatment modalities were not considered in this review.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-08-08 11:59:04 -0400" MODIFIED_BY="[Empty name]">
<P>The principal outcome measures of interest were taken from a core set of instruments recommended for low-back pain research and included: 1) Pain (typically measured using a visual analogue scale (VAS)); 2) Back-specific functional status (e.g. Roland Morris Disability Scale or Oswestry Disability Index); 3) Generic health status (e.g. SF-36); 4) Work Disability (e.g. loss of work, sick days); and 5) Patient satisfaction (<LINK REF="REF-Bombardier-2000" TYPE="REFERENCE">Bombardier 2000</LINK>; <LINK REF="REF-Deyo-1998" TYPE="REFERENCE">Deyo 1998</LINK>; <LINK REF="REF-Schaufele-2003" TYPE="REFERENCE">Schaufele 2003</LINK>). Treatment side-effects also constituted a primary outcome. Physical examination measures such as range of motion, finger-to-floor distance, degrees of straight leg raising, and muscle strength were considered secondary outcomes as were medication use and use of medical services.<BR/>
</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-08-13 09:09:35 -0400" MODIFIED_BY="[Empty name]">
<P>We initially searched the Cochrane Central Register of Controlled Trials (Issue 1, 2005), MEDLINE, EMBASE and the Physiotherapy Evidence Database (<LINK REF="REF-PEDro" TYPE="REFERENCE">PEDro</LINK>) from their beginning up to April 2005. Conference proceedings and reference lists from guidelines, literature reviews and retrieved articles were screened for further identification of relevant work. Content experts were contacted for additional studies. If sufficient data could not be obtained, abstracts were not used. No language restrictions were applied.</P>
<P>The sensitive search strategy for RCTs described by <LINK REF="REF-Haynes-1994" TYPE="REFERENCE">Haynes 1994</LINK> was used and combined with textwords and MeSH terms to identify TENS and low-back pain. See <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for details.</P>
<P>For this update, we consulted with the Trials Search Co-ordinator from the Cochrane Back Review Group, since guidelines for search strategies have been modified since the original review. Based on the new search strategy, described in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>, we searched the Cochrane Central Register of Controlled Trials (Issue 3, 2007), MEDLINE, EMBASE and PEDRO from 2004 to July 19, 2007. We also searched CINAHL from its beginning to July 19, 2007 since this database was not used previously. In addition, the International Clinical Trials Registry was searched for ongoing trials.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-08-13 09:09:35 -0400" MODIFIED_BY="[Empty name]">
<P>Two review authors (DO, AK) independently selected the studies to be considered for the review by screening the titles, abstracts and keywords of articles identified in the literature search. The full-text of all potentially relevant studies was retrieved for closer examination, including studies for which a decision about eligibility could not be reliably made based on the title, abstract and keywords alone. Disagreement about inclusion or exclusion of individual studies was resolved by discussion between the review authors. The review authors were not blinded to the authors, institution, date or journal of publication. There was no selection cut-off based on methodological quality or source of financial support. From each included trial, we collected information about the study design, study population, treatment characteristics (TENS device, stimulation settings, application method, treatment schedule, concurrent interventions), study outcomes and adverse effects. Differences in data extraction between review authors were resolved by referring back to the original article and establishing consensus. Additional information was sought from the authors of the primary studies when incompletely reported in the publications.</P>
<P>Where appropriate, data on the outcomes from each trial were pooled to arrive at an overall estimate of the effectiveness of TENS. Whenever possible, the analyses were based on intention-to-treat data from the individual trials. In cases where trials reported outcomes as graphs, the mean scores and standard deviations were estimated from these graphs.</P>
<P>For continuous data, the results were presented as mean differences (MD). However, when different scales were used to measure the same outcome, standardized mean differences (SMD) were used. For dichotomous data, an odds ratio (OR) was calculated (<LINK REF="REF-Petitti-1994" TYPE="REFERENCE">Petitti 1994</LINK>). Because the prevalence of the outcome studied is high, the OR cannot be interpreted as being equivalent to the relative risk (<LINK REF="REF-Henneken-1987" TYPE="REFERENCE">Henneken 1987</LINK>). A test for heterogeneity was calculated using an I<SUP>2</SUP> test. Fixed-effects models were used throughout, unless statistical heterogeneity was significant, in which case, a random-effects model was used. Subgroup analysis, sensitivity analysis and tests of publication bias were not performed due to the small number of trials that were included.</P>
<P>Based on a review of the low-back pain literature on minimal clinically important differences (MCID), we considered a mean difference in VAS scores of between 15 mm and 20 mm on a 0 to 100 mm scale to be clinically important (<LINK REF="REF-Hagg-2003" TYPE="REFERENCE">Hagg 2003</LINK>; <LINK REF="REF-Ostelo-2005" TYPE="REFERENCE">Ostelo 2005</LINK>; <LINK REF="REF-Ostelo-2008" TYPE="REFERENCE">Ostelo 2008</LINK>). For the Oswestry Disability Index, a mean difference of at least 10 points was considered clinically important (<LINK REF="REF-Davidson-2002" TYPE="REFERENCE">Davidson 2002</LINK>; <LINK REF="REF-Hagg-2003" TYPE="REFERENCE">Hagg 2003</LINK>; <LINK REF="REF-Ostelo-2005" TYPE="REFERENCE">Ostelo 2005</LINK>; <LINK REF="REF-Ostelo-2008" TYPE="REFERENCE">Ostelo 2008</LINK>) and for the Roland-Morris Disability Questionnaire, a mean difference of three points was taken as clinically important (<LINK REF="REF-Bombardier-2001" TYPE="REFERENCE">Bombardier 2001</LINK>; <LINK REF="REF-Ostelo-2005" TYPE="REFERENCE">Ostelo 2005</LINK>). The MCID for the Low Back Pain Outcome Scale has been reported to be 7.5 points (<LINK REF="REF-Muller-2006" TYPE="REFERENCE">Muller 2006</LINK>). Pooled effects sizes were considered small for standardized mean differences (SMD) between 0.2 to 0.5, moderate for SMDs between 0.5 to 0.8 and large for SMDs above 0.8 (<LINK REF="REF-Cohen-1988" TYPE="REFERENCE">Cohen 1988</LINK>). The criteria for clinically relevant outcomes were changed from that of the original protocol, which defined a 15% improvement from baseline relative to placebo as clinically important. The latter criterion was based on the consensus opinion of the Philadelphia Panel and study data regarding multiple rheumatological conditions (<LINK REF="REF-Philadelphia-Panel-2001" TYPE="REFERENCE">Philadelphia Panel 2001</LINK>). Since then, research on outcome measures for LBP has progressed considerably.</P>
<P>When the statistical pooling of data was not possible, a qualitative synthesis was performed in which five levels of evidence were taken into consideration, as recommended by the Cochrane Back Review Group (<LINK REF="REF-Van-Tulder-2003" TYPE="REFERENCE">Van Tulder 2003</LINK>).</P>
<UL>
<LI>
<B>Strong</B> - consistent findings among multiple high quality RCTs</LI>
<LI>
<B>Moderate </B>- consistent findings among multiple low quality RCTs and/or one high quality RCT</LI>
<LI>
<B>Limited</B> - one low quality RCT</LI>
<LI>
<B>Conflicting</B> - inconsistent findings among multiple RCTs</LI>
<LI>
<B>No evidence from trials</B> - no RCTs.</LI>
</UL>
<P>The criterion for a consistent finding was defined as at least 75% of the studies showing statistically significant and clinically relevant outcomes in the same direction.</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2008-08-13 09:09:35 -0400" MODIFIED_BY="[Empty name]">
<P>Overall, the literature search identified 47 potentially relevant studies, four of which were included for this review (N = 585; <LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK>; <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>; <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>; <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK>). A journal article published by Cheing et al in 1999 and one of their earlier 1996 abstracts, appearing in the conference proceedings of the 8th World Congress of Pain, were based on the same trial, but each reported data at different timepoints (one day versus two weeks) (<LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK>). For this study, the outcomes obtained at the end of the treatment phase were considered for analysis. Additional statistical data not reported in the abstract or journal publication were obtained from the primary authors. An ongoing study of 206 subjects entitled, Pain Reducing Effects of Transcutaneous Electrical Nerve Stimulation in Patients with Chronic Low Back Pain or Lumbo-Radiculalgia, was identified and is expected to be completed by October 2008 (<LINK REF="STD-Laurent-2008" TYPE="STUDY">Laurent 2008</LINK>).</P>
<P>The most common reason for study exclusion was the absence of a placebo-control group. Several trials were excluded because they assessed a mixed study population with acute, subacute and chronic low-back pain. Five trials were ineligible because they used needles that were inserted percutaneously. Altogether, six trials were excluded because they were conducted in an inpatient setting, had an inadequate sample size (five subjects per treatment group or less) or recruited subjects with inflammatory conditions such as ankylosing spondylitis. After considerable discussion, a study involving patients with multiple sclerosis (MS) was ultimately excluded because MS is a chronic, inflammatory disorder of the central nervous system, in which non-mechanical factors, namely demyelinating lesions of the spinal cord, may contribute to back pain. One potentially relevant cross-over study that did not report the means and standard deviations for its outcomes had to be excluded because requests for additional data were not returned (<LINK REF="STD-Jarzem-2005b" TYPE="STUDY">Jarzem 2005b</LINK>). A full list of the excluded trials and explanations for their ineligibility are provided in the <I>Characteristics of Excluded Studies</I> Table.</P>
<P>Individually, the four included RCTs (four trials, N = 585) recruited as few as 30 subjects and up to as many as 350 subjects (<LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK>; <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>; <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>; <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK>). The treatment phase of these trials lasted between two and four weeks, with daily treatment sessions ranging from 20 minutes to three hours per day. Precise stimulation parameters were reported in every trial, except one (<LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>). Nu-wave TENS, which was investigated by <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>, was not considered in this review because it did not constitute a standard form of TENS. Percutaneous neuromodulation therapy, a treatment modality investigated by <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK>, was not considered either because it involved the insertion of acupuncture-like needles. In two of the studies, subjects were instructed to self-administer TENS treatments at home (<LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>; <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>), whereas, in the remaining studies, a therapist was assigned to deliver treatments in the clinic setting (<LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK>; <LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK>). The stimulating electrodes, ranging between two and four in number, were generally placed over the area of maximal pain or within the same dermatome. However, the positioning of the electrodes was adjusted according to individual preference in one study (<LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>) or moved as necessary to maximize pain relief in another study (<LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>). Since prior exposure to TENS could affect the adequacy of patient blinding, it is notable that <LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK> did not specifically report the exclusion of subjects who had previous exposure to TENS.</P>
<P>Concurrent interventions were assigned in two studies: <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK> assigned an exercise program to the experimental and control groups and <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK> provided local heat and postural advice. Although no restrictions on the use of pain medication were applied in most of the studies, <LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK> demanded that subjects discontinue medication use and physiotherapy two weeks before the start of the trial. <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK> excluded subjects receiving either concomitant physiotherapy or chiropractic therapy.</P>
<P>Regarding the study population, a predominantly female sample was recruited by <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK> and a predominantly male sample was recruited by <LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK>. The mean age of subjects ranged from 28 to 51, depending on the particular study and treatment group in question. Two studies included patients with prior back surgery, representing as much as 18% (<LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>) and as little as 10% (<LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>) of the total patient sample. The latter study (<LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>) also included subjects with sciatica, which, again, constituted a minority of the overall study sample.<BR/>
<BR/>Outcomes at two-week and two-month follow-up were examined by <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>, but the raw data were not presented. No other studies reported long-term follow-up outcomes (see <I>Characteristics of Included Studies </I>table).<BR/>
</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-08-13 09:09:35 -0400" MODIFIED_BY="[Empty name]">
<P>The quality of the studies was assessed independently by two review authors (DO, AK) based on a list of eleven methodological criteria recommended by the Cochrane Back Review Group (<LINK REF="REF-Van-Tulder-2003" TYPE="REFERENCE">Van Tulder 2003</LINK>) (see <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). Differences in scoring were resolved by consensus, which was reached for all trials. A third review author (GW) was consulted for additional guidance.</P>
<P>An arbitrary cut-off of six out of 11 criteria was used to distinguish studies of higher quality versus lower quality in accordance with the Back Review Group Method Guidelines for Systematic Reviews (<LINK REF="REF-Van-Tulder-2003" TYPE="REFERENCE">Van Tulder 2003</LINK>). Based on this cut-off, all of the included studies were considered to be of higher quality (<LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK>; <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>; <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>; <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK>) with six to eight criteria being met. Although six criteria were initially marked as unclear for the study by <LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK>, additional information was sought from and provided by the primary authors and it was determined that many of these criteria were indeed met. See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
<P>To summarize the risk of bias assessment, concealment of treatment allocation was unclear in two studies (<LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK>; <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>). Subjects were blinded in every trial but, as expected, blinding of the care provider was not clearly achieved in any. The outcome assessor was reported to have been blinded in only two studies (<LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>; <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>). At the designated three-month follow-up, <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK> found that only 70% of the subjects returned a diary documenting their visual analogue pain scores and other outcomes; therefore, for this study, the criteria for acceptable drop-out rate was not met. The drop-out rate observed for the trial by <LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK> was also large, at just above 26%. Intention-to-treat analysis was not clearly performed in any study.</P>
<P>Significant group baseline differences were reported in three studies (<LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK>; <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>; <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>). <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK> found significant differences in marital status between groups. <LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK> found statistically significant differences in age (mean age of 35 years in experimental group versus mean age of 28 years in placebo group). The clinical significance of these differences is likely to be low. A third study by <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK> found significant differences in mean education level between subjects receiving TENS versus those receiving placebo TENS (13.7 versus 14.9 years). When all four treatment groups assigned in this trial were considered, significant differences were observed for neurologic deficit and previous hospitalization due to back pain. The authors (<LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>) found no substantial changes in their results when these differences in baseline variables were adjusted for (data not shown).</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Conventional TENS versus placebo</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Pain Intensity</HEADING>
<P>Pain intensity was measured using the visual analogue scale (VAS) in three of the four included studies (N = 235 at randomization) (<LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>; <LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK> <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK>). All three studies were of high methodological quality, meeting at least six out of 11 criteria. Still, they differed in terms of sample size, study population, treatment setting (home versus clinic), treatment schedule and use of concurrent interventions. Because of the clinical heterogeneity among the trials, meta-analysis was considered inappropriate. Therefore, a qualitative synthesis of the evidence was undertaken.</P>
<P>Individually, the three studies showed inconsistent results regarding the effect of TENS on low-back pain intensity. Two of the studies showed statistically insignificant and clinically unimportant benefits at the end of two weeks and four weeks of treatment respectively (<LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK>; <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>). Both <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK> (N =145 at randomization) and <LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK> (N = 30) assigned subjects to conventional TENS, but offered the choice of switching to acupuncture-like TENS at the midway-point of the four-week trial. Notably, the improvement in VAS scores midway through the four week treatment phase were described as statistically insignificant (data not shown). In contrast to these results, a third study (<LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK>) demonstrated both statistically significant and clinically important benefits following two weeks of treatment with conventional TENS (MD -21.80; 95% CI -33.08 to -10.52). What accounts for the discrepancy in results cannot be meaningfully explored due to the small number of trials involved (<LINK REF="REF-Higgins-2006" TYPE="REFERENCE">Higgins 2006</LINK>).</P>
<P>In summary, there is conflicting evidence about whether TENS improves chronic LBP intensity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Back-specific Functional Status</HEADING>
<P>Back-specific functional status was reported in two of the four studies (N = 410 at randomization; <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>; <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK>), using different, but well-validated scales. The Oswestry Disability Index and the Low Back Pain Outcome scale were reported in one study (<LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK>) and the Roland -Morris Disability Questionnaire (<LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>) was reported in the other. Again, clinical heterogeneity precluded meta-analysis and a qualitative analysis was performed. Individually, the smaller study (N = 60 at randomization) by <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK> showed no statistically significant or clinically important effects of conventional TENS with the Oswestry Disability Index or the Low Back Pain Outcome Scale. Similarly, <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK> (N = 350 at randomization) observed no statistically significant or clinically important effects of conventional TENS with the Roland-Morris Disability Questionnaire.</P>
<P>Regarding acupuncture-like TENS, <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK> did not find statistically significant benefits with the Low Back Pain Outcome Scale. At the same time, while statistically significant improvements were found with the Oswestry Disability Index, these were clinically unimportant (MD - 6.07; 95% CI -10.52 to -1.62). The larger study by <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK> found no statistically significant effects of acupuncture-like TENS with the Roland-Morris Disability Questionnaire.</P>
<P>There is consistent evidence in individual trials that TENS does not improve back-specific functional status to a clinically important degree regardless of whether conventional or acupuncture-like TENS is used.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Generic Health Status</HEADING>
<P>Generic health status was assessed in two studies, using the modified Sickness Impact Profile (<LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>) and the SF-36 (<LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK>) respectively. Statistical pooling was not possible because of differences in the way these two outcome measures are reported. Whereas, the larger study by <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK> showed no statistically significant effects with the modified Sickness Impact Profile, <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK> showed statistically significant benefits for conventional TENS on four out of eight subsections of the SF-36 (Physical Role Limitations, Emotional Role Limitations, General Mental Health, Vitality). Regarding acupuncture-like TENS, <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK> found statistically significant benefits on just two of the eight subsections of the SF-36 (Emotional Role Limitations, General Mental Health).</P>
<P>Based on the available studies, the effects of TENS on generic health status are conflicting.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Work Status</HEADING>
<P>Work status was assessed in one study (N = 350; <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>) using the McGill Work Scale, which demonstrated no significant differences between TENS and placebo.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Other Outcome Measures</HEADING>
<P>In terms of physical outcome measures, the only two studies that evaluated these outcomes (<LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>; <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>) found insignificant results, with the exception of the isometric dead-lift test, which seemed to improve after treatment with acupuncture-like TENS relative to placebo.</P>
<P>No significant differences between TENS and placebo were identified by <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK> for the use of medical services or by <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK> for the Zung depression scale (data not shown).</P>
<P>With regards to various activity-related measures, <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK> demonstrated a statistically significant improvement in activity pain after treatment with either conventional TENS (MD -17.20; 95% CI - 27.38 to -7.02) or acupuncture-like TENS (MD -12.50; 95% CI -24.47 to -0.53). However, the latter outcome was not clinically relevant. At the same time, <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK> found no statistically significant benefits of TENS treatment with respect to self-rated activity and <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK> found no statistically significant benefits from either conventional or acupuncture-like TENS with the McGill Activity Scale.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Conventional TENS and Acupuncture-like TENS</HEADING>
<P>What is particularly noteworthy is that the two studies that separately compared conventional TENS and acupuncture-like TENS to placebo (<LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>; <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK>) showed similar results for either TENS mode on most outcomes. The only exceptions included the isometric dead-lift test, two subsections of the SF-36 questionnaire (Physical Role Limitations, Vitality) and activity-pain.</P>
<SUBSECTION>
<HEADING LEVEL="4">Adverse Effects</HEADING>
<P>In terms of adverse effects, <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK> found that in a third of the participants, minor skin irritation occurred at the site of electrode placement. These adverse effects were observed equally in the TENS and placebo groups. One participant randomized to the placebo group developed severe dermatitis four days after the start of therapy and was required to withdraw from the trial. The presence or absence of adverse effects was not reported in the other three studies (<LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK>; <LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>; <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK>).<BR/>
<BR/>Please note that a short-term cross-over trial conducted by <LINK REF="STD-Jarzem-2005b" TYPE="STUDY">Jarzem 2005b</LINK> could not be included in the analysis because usable data was not reported. The authors of the study described positive results for conventional TENS with regard to pain intensity and various physical outcome measures after a maximum of one or two treatment sessions per subject.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-08-11 13:43:45 -0400" MODIFIED_BY="[Empty name]">
<P>Despite a strong theoretical framework and widespread use, our synthesis of the currently available evidence (four RCTs, 585 subjects) suggests that TENS is not clearly more effective than placebo for the management of chronic LBP. All four included RCTs were considered to be of reasonably high quality, meeting at least six out of 11 methodological criteria recommended by the Cochrane Back Review Group (<LINK REF="REF-Van-Tulder-2003" TYPE="REFERENCE">Van Tulder 2003</LINK>). While one smaller study (N = 60; <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK>) described some significant benefits with TENS, the remaining three studies under review did not, including two larger trials with sample sizes of 145 (<LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK>) and 350 subjects (<LINK REF="STD-Jarzem-2005a" TYPE="STUDY">Jarzem 2005a</LINK>). Larger trials yield more precise estimates of treatment efficacy and are less susceptible to publication bias (<LINK REF="REF-Montori-2000" TYPE="REFERENCE">Montori 2000</LINK>; <LINK REF="REF-Sterne-2001" TYPE="REFERENCE">Sterne 2001</LINK>). Disappointingly, only one of the four trials reported the presence or absence of adverse effects. In this single trial, adverse effects consisted of minor skin irritation at the site of electrode placement that was experienced by approximately a third of the subjects.</P>
<P>The conclusions drawn here are in relative agreement with previous systematic reviews. For example, <LINK REF="REF-Van-Tulder-1999" TYPE="REFERENCE">Van Tulder 1999</LINK> and <LINK REF="REF-Van-Tulder-1997" TYPE="REFERENCE">Van Tulder 1997</LINK> found contradictory results from three eligible trials and, thereby, concluded that there was no clear evidence to support the use of TENS. <LINK REF="REF-Flowerdew-1997" TYPE="REFERENCE">Flowerdew 1997</LINK> and <LINK REF="REF-Gadsby-2000" TYPE="REFERENCE">Gadsby 2000</LINK> stated that a definitive study was yet to be conducted after reviewing six eligible trials and finding only limited statistical evidence for a short-term benefit of TENS treatment. Several clinical guidelines have been produced over the last decade that further reinforce the findings of the current systematic review. The Philadelphia Panel (<LINK REF="REF-Philadelphia-Panel-2001" TYPE="REFERENCE">Philadelphia Panel 2001</LINK>) found poor evidence to recommend including or excluding TENS in the management of chronic LBP based on an evaluation of five eligible trials. A similar conclusion was drawn by the American Pain Society and the American College of Physicians, which looked at approximately nine studies exploring the benefits of TENS for subacute and chronic LBP (<LINK REF="REF-Chou-2007a" TYPE="REFERENCE">Chou 2007a</LINK>; <LINK REF="REF-Chou-2007b" TYPE="REFERENCE">Chou 2007b</LINK>). They considered head-to-head studies comparing TENS to other conservative therapies in their review of the evidence. The latest European guidelines on chronic LBP also did not recommend TENS, suggesting that there was strong evidence that TENS was not more effective than placebo and moderate evidence that it was not more effective than acupuncture, electroacupuncture, percutaneous electrical nerve stimulation (PENS) or vertebral axial decompression (<LINK REF="REF-Hildebrandt-2004" TYPE="REFERENCE">Hildebrandt 2004</LINK>). In contrast to our conclusions, the Quebec Task Force guidelines recommended TENS for chronic LBP (<LINK REF="REF-QTF-1987" TYPE="REFERENCE">QTF 1987</LINK>). However, the QTF did not distinguish TENS from other forms of electrotherapy and was convened before any of the currently included studies were published.</P>
<P>It should be emphasized that this review applies only to standard modes of TENS (conventional, acupuncture-like, brief-intense, burst, and modulation). No attempt was made to examine the pain-relieving effects of other forms of electroanalgesia (e.g. PENS, electroacupuncture, neuromuscular electrical stimulation, interferential therapy, electrical spinal cord stimulation or other variant TENS-like applications). Closer study of these alternative, invasive and non-invasive forms of electrotherapy is warranted with particular attention given to risk-benefit ratios.</P>
<P>Optimal stimulation parameters and treatment schedules for TENS in chronic LBP are poorly defined. With few exceptions, the two studies that separately compared conventional TENS and acupuncture-like TENS to placebo showed similar results for either treatment mode. However, neither study used a sufficient stimulation intensity for the subjects receiving acupuncture-like TENS, since muscle twitching was not induced (<LINK REF="REF-Belanger-2002" TYPE="REFERENCE">Belanger 2002</LINK>; <LINK REF="REF-Sluka-2003" TYPE="REFERENCE">Sluka 2003</LINK>). Because the individual response to various treatment parameters (frequency, pulse width, amplitude) may be quite variable (<LINK REF="REF-Johnson-1991a" TYPE="REFERENCE">Johnson 1991a</LINK>; <LINK REF="REF-Johnson-1991b" TYPE="REFERENCE">Johnson 1991b</LINK>; <LINK REF="REF-Tulgar-1991" TYPE="REFERENCE">Tulgar 1991</LINK>), future RCTs investigating the effects of TENS might consider a trial and error approach using different stimulation modes to determine an individual subject's optimal response before treatment assignment. Of note, <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK> allowed subjects being treated with conventional TENS to try acupuncture-like TENS midway through the four week treatment phase and choose which mode they preferred for the remaining half of the study (77% chose acupuncture-like TENS).</P>
<P>There is little evidence to guide decisions on the optimal treatment duration and the small number of studies reviewed here did not permit meaningful clarification. Since post-stimulation analgesia following TENS therapy may be limited, especially with conventional TENS (<LINK REF="REF-Belanger-2002" TYPE="REFERENCE">Belanger 2002</LINK>), there is a rationale for using prolonged application times, divided as multiple sessions throughout the day, to ensure continued and maximal pain relief. It should be noted that the only positive trial in this review assigned just 20 minutes of treatment per day, whereas the three negative trials assigned 60 minutes or more of daily treatment. Tolerance to the analgesic effects of TENS following prolonged stimulation could be argued as a potential contributing factor to the negative outcomes of some of the studies. However, this is, at best, speculative. It may be informative to formally test the effects of different daily treatment durations in a randomized-controlled trial over a period of four weeks or longer. Modulation TENS, a treatment mode in which the stimulation parameters are randomly altered over the course of a therapy session, has been proposed to reduce the chances of stimulus adaptation (<LINK REF="REF-Tulgar-1991" TYPE="REFERENCE">Tulgar 1991</LINK>) and might be considered if the development of tolerance is an issue. What is significant in this regard is that <LINK REF="STD-Deyo-1990a" TYPE="STUDY">Deyo 1990a</LINK> used a modulated pulse rate, where the frequency of stimulation was periodically altered to arrive at a specified average frequency. Still, no therapeutic benefits were observed. Given that cross-tolerance between the effects of TENS and opioids has been described (<LINK REF="REF-Sluka-1999" TYPE="REFERENCE">Sluka 1999</LINK>), it would have been interesting to know how many subjects used opioids in the three trials that permitted analgesic medication use.</P>
<P>It is arguable that the use of concurrent interventions in the two larger, negative trials could have masked the effect of TENS relative to placebo. However, determining the additional benefit of TENS in the context of a multi-modal treatment strategy is much more informative as this better reflects clinical practice. Given that NSAID use for chronic LBP is common and that <LINK REF="STD-Topuz-2004" TYPE="STUDY">Topuz 2004</LINK> did not specifically restrict the use of analgesic medications, concurrent interventions were not entirely avoided even in this single, positive trial. Additionally, although <LINK REF="STD-Cheing-1996" TYPE="STUDY">Cheing 1996</LINK> required that subjects terminate the use of pain medications as well as physiotherapy services two weeks prior to the study, the effect of TENS treatment was found to be clinically and statistically insignificant.</P>
<P>Several limitations to this systematic review deserve consideration. First and foremost, there was only a small number of eligible trials from which to draw conclusions. In addition, the same outcome measures were not consistently reported in each of the included trials, making comparisons more difficult. The criteria used in this review to define clinically important differences in outcome between TENS and placebo are still evolving and should be interpreted with caution. Although empirical evidence dealing specifically with LBP exists to support these criteria, the evidence was based partly on changes observed within individual patients and partly on group changes (<LINK REF="REF-Bombardier-2001" TYPE="REFERENCE">Bombardier 2001</LINK>; <LINK REF="REF-Davidson-2002" TYPE="REFERENCE">Davidson 2002</LINK>; <LINK REF="REF-Hagg-2003" TYPE="REFERENCE">Hagg 2003</LINK>; <LINK REF="REF-Muller-2006" TYPE="REFERENCE">Muller 2006</LINK>; <LINK REF="REF-Ostelo-2005" TYPE="REFERENCE">Ostelo 2005</LINK>, <LINK REF="REF-Ostelo-2008" TYPE="REFERENCE">Ostelo 2008</LINK>). Without ready access to individual patient data, we relied on mean group differences to judge clinically relevant outcomes. Some relevant studies might have been missed in the literature search due to unclear abstracts or the use of different keywords by authors. However, our search strategy was newly revised and an additional electronic database was included so this is unlikely to be a major issue. As previously mentioned at the end of the results section, a short-term cross-over trial comparing conventional TENS to placebo in patients with chronic low-back pain described statistically significant benefits for TENS with respect to pain intensity and various physical outcome measures (<LINK REF="STD-Jarzem-2005b" TYPE="STUDY">Jarzem 2005b</LINK>). How the inclusion of this trial would have affected the overall conclusions of the review cannot be answered since usable data could not be obtained for analysis. The clinical relevance of this study appears limited given that it was carried out over just a single day with subjects receiving only one or two sessions of active TENS treatment in total.</P>
<P>Given the lack of consistent evidence to support the use of TENS in the more restricted study populations reviewed here, widening the selection criteria to include all causes of chronic LBP might be considered in future updates. Moreover, future updates will look at the effectiveness of TENS relative to other treatment modalities.</P>
<P>In summary, there is inconsistent evidence from a small number of placebo-controlled trials to support the use of TENS in the routine management of chronic LBP. Further research is encouraged.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2008-08-11 12:01:22 -0400" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2008-08-11 12:01:22 -0400" MODIFIED_BY="[Empty name]">
<P>The evidence from four placebo-controlled RCTs (585 patients) fails to consistently demonstrate that TENS relieves the symptoms and reduces the disability associated with chronic LBP.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-08-08 11:59:32 -0400" MODIFIED_BY="[Empty name]">
<P>The possibility that optimal stimulation parameters and treatment schedules exist for TENS in the management of chronic LBP needs to be better defined. The use of standardized outcome measures as recently outlined by <LINK REF="REF-Bombardier-2000" TYPE="REFERENCE">Bombardier 2000</LINK>, <LINK REF="REF-Deyo-1998" TYPE="REFERENCE">Deyo 1998</LINK> and <LINK REF="REF-Schaufele-2003" TYPE="REFERENCE">Schaufele 2003</LINK> greatly facilitates systematic analysis. Due to the natural fluctuations of symptoms in chronic LBP, baseline, end-of-treatment and follow-up outcome measures should ideally be measured over multiple days and at different times of the day (<LINK REF="REF-Von-Korff-1996" TYPE="REFERENCE">Von Korff 1996</LINK>). Appropriate reporting of results is encouraged, with means and standard deviations provided for each treatment outcome as well as for relevant baseline characteristics. Monitoring the use of analgesic medications is important since variable and unequal use between groups may represent a confounding factor or, alternatively, a treatment benefit. Reporting the presence or absence of adverse effects is essential. Short-term treatment trials under two weeks in duration have limited relevance for chronic LBP. Post-treatment follow-up assessments should be conducted to determine the durability of treatment effects. Finally, given the increasing recognition of the problem of recurrent low-back pain as distinct from chronic low-back pain, investigating the therapeutic benefits of TENS in this population at the time of a recurrence may be useful.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>The authors wish to thank Rachel Couban for her assistance with the literature search and Victoria Pennick for important feedback. We would also like to thank Sarah Milne, Vivian (Robinson) Welch, Michael Saginur, Beverley Shea and Peter Tugwell for their contributions to earlier versions of this work.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None<BR/> </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-06-06 13:15:32 -0400" MODIFIED_BY="[Empty name]">
<P>Amole Khadilkar participated in the selection of trials, assessment of methodological quality, data extraction, statistical analysis and conclusions for the current update.</P>
<P>Daniel Oluwafemi Odebiyi assisted with the study selection, methodological quality assessment and data extraction for the current update.</P>
<P>George Wells provided statistical consultation and overall guidance.</P>
<P>Lucie Brosseau developed the original protocol.</P>
<P>Sarah Milne, Vivian (Robinson) Welch, Lucie Brosseau, Michael Saginur, Beverley Shea, Peter Tugwell and George Wells were involved in the original review</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2013-03-31 12:14:05 -0400" MODIFIED_BY="[Empty name]">
<P>This review is currently being updated and will be replaced by a review with the following title: Transcutaneous electrical nerve stimulation (TENS) for chronic low-back pain. The protocol for the new review is now available in <I>The Cochrane Library </I>(<LINK REF="REF-Odebiyi-2013" TYPE="REFERENCE">Odebiyi 2013</LINK>).</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-04-30 10:13:10 -0400" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Cheing-1996" MODIFIED="2008-06-06 11:51:46 -0400" MODIFIED_BY="[Empty name]" NAME="Cheing 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-06-06 11:51:46 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cheing GL, Hui-Chan CW</AU>
<TI>Transcutaneous electrical nerve stimulation: nonparallel antinociceptive effects on chronic clinical pain and acute experimental pain</TI>
<SO>Archives of Physical Medicine &amp; Rehabilitation</SO>
<YR>1999</YR>
<VL>80</VL>
<NO>3</NO>
<PG>305-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Cheing GLY, Hui-Chan CWY</AU>
<TI>Repeated application of TENS produce cumulative effects on chronic clinical pain but not acute experimental pain in chronic low back patients</TI>
<SO>The 8th World Congress on Pain</SO>
<YR>1996</YR>
<VL>8</VL>
<PG>85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Deyo-1990a" MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NAME="Deyo 1990a" YEAR="1990">
<REFERENCE MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Deyo RA, Walsh NE, Martin DC, Schoenfield LS, Ramamurthy S. A Controlled Trial of Transcutaneous Electrical Stimulation (TENS) and Exercise for Chronic Low Back Pain. New England Journal of Medicine, June 7, 1990; 322(23): 1627-1634.&lt;/p&gt;" NOTES_MODIFIED="2008-08-13 09:42:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Deyo RA, Walsh NE, Martin DC, Schoenfield LS, Ramamurthy S</AU>
<TI>A controlled trial of transcutaneous electrical stimulation (TENS) and exercise for chronic low back pain</TI>
<SO>New England Journal of Medicine</SO>
<YR>1990</YR>
<VL>322</VL>
<NO>23</NO>
<PG>1627-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jarzem-2005a" MODIFIED="2008-06-06 12:00:45 -0400" MODIFIED_BY="[Empty name]" NAME="Jarzem 2005a" YEAR="2005">
<REFERENCE MODIFIED="2008-06-06 12:00:45 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Jarzem P, Harvey EJ, Arcaro N, Kazarowski J</AU>
<TI>Transcutaneous electrical nerve stimulation for non-acute low back pain: A randomized double-blind study of conventional, Nu-Wavefor, acupuncture-type and sham therapies</TI>
<SO>American Academy of Orthopaedic Surgeons Annual Meetiing</SO>
<YR>1997</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jarzem PF, Harvey EJ, Arcaro N, Kaczorowski J</AU>
<TI>Transcutaneous electrical nerve stimulation (TENS) for chronic low back pain</TI>
<SO>Journal of Musculoskeletal Pain</SO>
<YR>2005</YR>
<VL>13</VL>
<NO>2</NO>
<PG>3-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Topuz-2004" MODIFIED="2008-06-06 11:54:37 -0400" MODIFIED_BY="[Empty name]" NAME="Topuz 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-06-06 11:54:37 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Topuz O, Ozfidan E, Ozgen M, Ardic F</AU>
<TI>Efficacy of transcutaneous electrical nerve stimulation and percutaneous electrical neuromodulation therapy in chronic low back pain</TI>
<SO>Journal of Back and Musculoskeletal Rehabilitation</SO>
<YR>2004</YR>
<VL>17</VL>
<PG>127-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Al_x002d_Smadi-2003" MODIFIED="2008-08-11 14:46:45 -0400" MODIFIED_BY="[Empty name]" NAME="Al-Smadi 2003" YEAR="3003">
<REFERENCE MODIFIED="2008-08-11 14:46:45 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Al-Smadi J, Warke K, Wilson I, Cramp AF, Noble G, Walsh DM, Lowe-Strong AS</AU>
<TI>A pilot investigation of the hypoalgesic effects of transcutaneous electrical nerve stimulation upon low back pain in people with multiple sclerosis</TI>
<SO>Clinical Rehabilitation</SO>
<YR>2003</YR>
<VL>17</VL>
<NO>7</NO>
<PG>742-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Biedermann-1987" NAME="Biedermann 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Biedermann HJ, McGhie A, Monga TN, Shanks GL. Perceived and actual control in EMG treatment of back pain. Behaviour Research &amp;amp; Therapy 1987; 25(2): 137-147&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Biedermann HJ, McGhie A, Monga TN, Shanks GL</AU>
<TI>Perceived and actual control in EMG treatment of back pain</TI>
<SO>Behaviour Research &amp; Therapy</SO>
<YR>1987</YR>
<VL>25</VL>
<NO>2</NO>
<PG>137-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bloodworth-2004" MODIFIED="2008-08-11 14:47:28 -0400" MODIFIED_BY="[Empty name]" NAME="Bloodworth 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-08-11 14:47:28 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bloodworth DM, Nguyen BN, Garver W, Moss F, Pedroza C, Tran T, Chiou-Tan FY</AU>
<TI>Comparison of stochastic vs. conventional transcutaneous electrical stimulation for pain modulation in patients with electromyographically documented radiculopathy</TI>
<SO>American Journal of Physical Medicine &amp; Rehabilitation</SO>
<YR>2004</YR>
<VL>83</VL>
<NO>8</NO>
<PG>584-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cheng-1987" NAME="Cheng 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cheng RSS, Pomeranz B</AU>
<TI>Electrotherapy of chronic musculoskeletal pain: comparison of electroacupuncture and acupuncture-like transcutaneous electrical stimulation</TI>
<SO>Clinical Journal of Pain</SO>
<YR>1987</YR>
<VL>2</VL>
<PG>143-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cubucku-2004" MODIFIED="2008-06-06 11:56:09 -0400" MODIFIED_BY="[Empty name]" NAME="Cubucku 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-06-06 11:56:09 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cubucku S, Karsli B, Alimoglu MK</AU>
<TI>Meralgia Paresthetica and low back pain</TI>
<SO>Journal of Back and Musculoskeletal Rehabilitation</SO>
<YR>2004</YR>
<VL>17</VL>
<NO>3-4</NO>
<PG>135-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fox-1976" MODIFIED="2008-06-09 11:37:54 -0400" MODIFIED_BY="[Empty name]" NAME="Fox 1976" YEAR="1976">
<REFERENCE MODIFIED="2008-06-09 11:37:54 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fox EJ, Melzac R</AU>
<TI>Transcutaneous electrical stimulation and acupuncture: comparison treatment for low back pain</TI>
<SO>Pain</SO>
<YR>1976</YR>
<VL>2</VL>
<PG>141-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gemignani-1991" MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NAME="Gemignani 1991" YEAR="1991">
<REFERENCE MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Gemigniani G. Transcutaneous Electrical Nerve Stimulation in Ankylosing Spondylitis: a Double-Blind Study. Arth Rheum 1991; 34(6): 788-789.&lt;/p&gt;" NOTES_MODIFIED="2008-08-13 09:42:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gemigniani G</AU>
<TI>Transcutaneous Electrical Nerve Stimulation in Ankylosing Spondylitis: a Double-Blind Study</TI>
<SO>Arth Rheum</SO>
<YR>1991</YR>
<VL>34</VL>
<NO>6</NO>
<PG>788-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghoname-1999a" MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NAME="Ghoname 1999a" YEAR="1999">
<REFERENCE MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Ghoname EA, Craig WF, White PF, Ahmed HE, Hamza MA, Henderson BN, Gajraj NM, Huber PJ, Gatchel RJ. Percutaneous Electrical Nerve Stimulation for Low Back Pain. JAMA, March 3, 1999; 281(9): 818-823.&lt;/p&gt;" NOTES_MODIFIED="2008-08-13 09:42:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ghoname EA, Craig WF, White PF, Ahmed HE, Hamza MA, Henderson BN, Gajraj NM, Huber PJ, Gatchel RJ</AU>
<TI>Percutaneous Electrical Nerve Stimulation for Low Back Pain</TI>
<SO>JAMA</SO>
<YR>1999</YR>
<VL>281</VL>
<NO>9</NO>
<PG>818-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghoname-1999b" MODIFIED="2008-06-06 11:57:09 -0400" MODIFIED_BY="[Empty name]" NAME="Ghoname 1999b" YEAR="1999">
<REFERENCE MODIFIED="2008-06-06 11:57:09 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ghoname EA, White PF, Hamza MA, Craig WF, Noe CE</AU>
<TI>Percutaneous electrical nerve stimulation: an alternative to TENS in the management of sciatica</TI>
<SO>Pain</SO>
<YR>1999</YR>
<VL>83</VL>
<NO>2</NO>
<PG>193-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glaser-2001" NAME="Glaser 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Glaser JA, Baltz MA, Nietart PJ, Bensen CV</AU>
<TI>Electrical muscle stimulation as an adjunct to exercise therapy in the treatment of nonacute low back pain: a randomized trial</TI>
<SO>The Journal of Pain</SO>
<YR>2001</YR>
<VL>2</VL>
<NO>5</NO>
<PG>295-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grant-1999" NAME="Grant 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grant D, Bishop-Miller J, Winchester D</AU>
<TI>A randomized comparative trial of acupuncture versus transcutaneous electrical nerve stimulation for chronic back pain in the elderly</TI>
<SO>Pain</SO>
<YR>1999</YR>
<VL>82</VL>
<PG>9-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hackett-1988" NAME="Hackett 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Hackett GI, Seddon D, Kaminski D. Electroacupuncture compared with paracetamol for acute low back pain. Practitioner 1988,Feb 22;232(1443):163-164&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hackett GI, Seddon D, Kaminski D</AU>
<TI>Electroacupuncture compared with paracetamol for acute low back pain</TI>
<SO>Practitioner</SO>
<YR>1988</YR>
<VL>232</VL>
<NO>1443</NO>
<PG>163-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hamza-1999" MODIFIED="2008-08-11 14:49:43 -0400" MODIFIED_BY="[Empty name]" NAME="Hamza 1999" YEAR="">
<REFERENCE MODIFIED="2008-08-11 14:49:43 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hamza M, Ghoname E, White P, Craig W, Ahmed H, Gajraj N, Vakharia AS, Noe CE</AU>
<TI>Effect of the duration of electrical stimulation on the analgesic response in patients with low back pain</TI>
<SO>Anesthesiology</SO>
<YR>1999</YR>
<VL>91</VL>
<NO>6</NO>
<PG>1622-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Herman-1994" MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NAME="Herman 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Herman E, Williams R, Stratford P, Fargas-Babjak A, Trott M. A Randomized Controlled Trial of Transcutaneous Electrical Nerve Stimulation (CODETRON) to determine its Benefits in a Rehabilitation Program for Acute Occupational Low Back Pain. SPINE 1994;19(5):561-568.&lt;/p&gt;" NOTES_MODIFIED="2008-08-13 09:42:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Herman E, Williams R, Stratford P, Fargas-Babjak A, Trott M</AU>
<TI>A randomized controlled trial of transcutaneous electrical nerve stimulation (CODETRON) to determine its benefits in a rehabilitation program for acute occupational low back pain</TI>
<SO>Spine</SO>
<YR>1994</YR>
<VL>19</VL>
<NO>5</NO>
<PG>561-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hsieh-2002" NAME="Hsieh 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hsieh RL, Lee WC</AU>
<TI>One-shot percutaneous electrical nerve stimulation vs. transcutaneous electrical nerve stimulation for low back pain: comparison of therapeutic effects</TI>
<SO>American Journal of Physical Medicine &amp; Rehabilitation</SO>
<YR>2002</YR>
<VL>81</VL>
<NO>11</NO>
<PG>838-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hurley-2001" NAME="Hurley 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hurley DA, Minder PM, McDonough SM, Walsh, DM, Moore AP, Baxter DG</AU>
<TI>Interferential therapy electrode placement technique in acute low back pain: a preliminary investigation</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>2001</YR>
<VL>82</VL>
<PG>485-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jarzem-2005b" MODIFIED="2008-08-11 14:20:08 -0400" MODIFIED_BY="[Empty name]" NAME="Jarzem 2005b" YEAR="2005">
<REFERENCE MODIFIED="2008-08-11 14:20:08 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jarzem PF, Harvey EJ, Arcaro N, Kaczorowski J</AU>
<TI>transcutaneous electrical nerve stimulation (TENS) for short-term treatment of low back pain - randomized double blind crossover study of sham versus conventional TENS</TI>
<SO>Journal of Musculoskeletal Pain</SO>
<YR>2005</YR>
<VL>13</VL>
<NO>2</NO>
<PG>11-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jeans-1979" MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NAME="Jeans 1979" YEAR="1979">
<REFERENCE MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Jeans ME. Relief of Chronic Pain by Brief, Intense Transcutaneous Electrical Stimulation - A Double-Blind Study. Advances in Pain Research and Therapy 1979; 3:601-606.&lt;/p&gt;" NOTES_MODIFIED="2008-08-13 09:42:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jeans ME</AU>
<TI>Relief of chronic pain by brief, intense transcutaneous electrical stimulation - A double-blind study</TI>
<SO>Advances in Pain Research and Therapy</SO>
<YR>1979</YR>
<VL>3</VL>
<PG>601-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laitinen-1976" NAME="Laitinen 1976" YEAR="1976">
<REFERENCE NOTES="&lt;p&gt;Laitinen J. Acupuncture and transcutaneous electric stimulation in the treatment of chronic sacrolumbalgia and ischialgia. American Journal of Chinese Medicine 1976 Summer; 4(2): 169-175&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laitinen J</AU>
<TI>Acupuncture and transcutaneous electric stimulation in the treatment of chronic sacrolumbalgia and ischialgia</TI>
<SO>American Journal of Chinese Medicine</SO>
<YR>1976</YR>
<VL>4</VL>
<NO>2</NO>
<PG>169-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lampe-1987" MODIFIED="2008-06-06 12:03:54 -0400" MODIFIED_BY="[Empty name]" NAME="Lampe 1987" YEAR="1987">
<REFERENCE MODIFIED="2008-06-06 12:03:54 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lampe J and Dunn B</AU>
<TI>Symmetrical biphasic TENS waveform for the treatment of back pain</TI>
<SO>The Clinical Journal of Pain</SO>
<YR>1987</YR>
<VL>3</VL>
<PG>145-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lehmann-1983" NAME="Lehmann 1983" YEAR="1983">
<REFERENCE NOTES="&lt;p&gt;Lehmann TR, Russell DW, Spratt KF. The impact of patients with nonorganic physical findings on a controlled trial of transcutaneous electrical nerve stimulation and electroacupuncture. Spine 1983 Sep ;8(6):625-634&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lehmann TR, Russell DW, Spratt KF</AU>
<TI>The impact of patients with nonorganic physical findings on a controlled trial of transcutaneous electrical nerve stimulation and electroacupuncture</TI>
<SO>Spine</SO>
<YR>1983</YR>
<VL>8</VL>
<NO>6</NO>
<PG>625-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lehmann-1986" MODIFIED="2008-08-11 14:50:21 -0400" MODIFIED_BY="[Empty name]" NAME="Lehmann 1986" YEAR="1986">
<REFERENCE MODIFIED="2008-08-11 14:50:21 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lehmann TR, Russel DW, Spratt KF, Colby H, Liu YK, Fairchild ML, Christensen S</AU>
<TI>Efficacy of electroacupuncture and TENS in the rehabilitation of chronic low back patients</TI>
<SO>Pain</SO>
<YR>1986</YR>
<VL>26</VL>
<PG>277-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lundeberg-1984" MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NAME="Lundeberg 1984" YEAR="1984">
<REFERENCE MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Lundeberg T. A Comparative Study of the Pain Alleviating Effect of Vibratory Stimulation, Transcutaneous Electrical Nerve Stimulation, Electroacupuncture and Placebo. American Journal of Chinese Medicine 1984; 12:72-79&lt;/p&gt;" NOTES_MODIFIED="2008-08-13 09:42:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lundeberg T</AU>
<TI>A comparative study of the pain alleviating effect of vibratory stimulation, transcutaneous electrical nerve stimulation, electroacupuncture and placebo</TI>
<SO>American Journal of Chinese Medicine</SO>
<YR>1984</YR>
<VL>12</VL>
<PG>72-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Macdonald-1995" NAME="Macdonald 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Macdonald AJR, Coates TW. The discovery of transcutaneous spinal electroanalgesia and its relief of chronic pain. Physiotherapy 1995 Nov; 81(11): 653-661&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Macdonald AJR, Coates TW</AU>
<TI>The discovery of transcutaneous spinal electroanalgesia and its relief of chronic pain</TI>
<SO>Physiotherapy</SO>
<YR>1995</YR>
<VL>81</VL>
<NO>11</NO>
<PG>653-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marchand-1993" MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NAME="Marchand 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Marchand S, Charest J, Li J, Chenard JR, Lavignolle B, Laurencelle L. Is TENS Purely a Placebo Effect? - A Controlled Study on Chronic Low Back Pain. Pain 1993;54():99-106.&lt;/p&gt;" NOTES_MODIFIED="2008-08-13 09:42:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Marchand S, Charest J, Li J, Chenard JR, Lavignolle B, Laurencelle L</AU>
<TI>Is TENS purely a placebo effect? A controlled study on chronic low back pain</TI>
<SO>Pain</SO>
<YR>1993</YR>
<VL>54</VL>
<NO>1</NO>
<PG>99-106</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Melzack-1980" MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NAME="Melzack 1980" YEAR="1980">
<REFERENCE MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Melzack R, Jeans ME, Stratford JG, Monks RC. Ice Massage and Transcutaneous Electrical Stimulation: Comparison of Treatment for Low-Back Pain. Pain, 1980; 9:209-217.&lt;/p&gt;" NOTES_MODIFIED="2008-08-13 09:42:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Melzack R, Jeans ME, Stratford JG, Monks RC</AU>
<TI>Ice massage and transcutaneous electrical stimulation: comparison of treatment for low-back pain</TI>
<SO>Pain</SO>
<YR>1980</YR>
<VL>9</VL>
<PG>209-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Melzack-1983" MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NAME="Melzack 1983" YEAR="1983">
<REFERENCE MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Melzack R, Vetere P, Finch L. Transcutaneous Electrical Nerve Stimulation for Low Back Pain - A Comparison of TENS for Pain and Range of Motion. Physical Therapy April 1983; 63(4): 489-493.&lt;/p&gt;" NOTES_MODIFIED="2008-08-13 09:42:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Melzack R, Vetere P, Finch L</AU>
<TI>Transcutaneous electrical nerve stimulation for low back pain - A comparison of TENS for pain and range of motion</TI>
<SO>Physical Therapy</SO>
<YR>1983</YR>
<VL>63</VL>
<NO>4</NO>
<PG>489-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moore-1997" MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NAME="Moore 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Moore SR, Shurman J. Combined Neuromuscular Electrical Stimulation and Transcutaneous Electrical Nerve Stimulation for Treatment of Chronic Back Pain: A Double-Blind, Repeated Measures Comparison. Arch Phys Med Rheabil 1997; 78: 55-60.&lt;/p&gt;" NOTES_MODIFIED="2008-08-13 09:42:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Moore SR, Shurman J</AU>
<TI>Combined neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation for treatment of chronic back pain: A double-blind, repeated measures comparison</TI>
<SO>Archives of Physical Medicine and Rehabilitation</SO>
<YR>1997</YR>
<VL>78</VL>
<NO>1</NO>
<PG>55-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pressor-2000" MODIFIED="2008-08-11 14:51:02 -0400" MODIFIED_BY="[Empty name]" NAME="Pressor 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-08-11 14:51:02 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Presser M, Birkhan J, Adler R, Hanani A, Eisenberg E</AU>
<TI>Transcutaneous electrical nerve stimulation (TENS) during epidural steroids injection: A randomized controlled trial</TI>
<SO>The Pain Clinic</SO>
<YR>2000</YR>
<VL>12</VL>
<NO>2</NO>
<PG>77-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Puranik-2002" NAME="Puranik 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Puranik S, Fozard J, Paremain G, Kilminster S, Hughes D, Williams E</AU>
<TI>A randomised, single blind study to evaluate the effects of action potential stimulator therapy compared with placebo in patients with chronic back pain</TI>
<SO>The Pain Clinic</SO>
<YR>2002</YR>
<VL>14</VL>
<NO>1</NO>
<PG>69-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rutkowski-1977" NAME="Rutkowski 1977" YEAR="1977">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rutkowski B, Niedzialkowska T, Otto J</AU>
<TI>Electrical stimulation in chronic low-back pain</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1977</YR>
<VL>49</VL>
<NO>6</NO>
<PG>629-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schuster-1980" NAME="Schuster 1980" YEAR="1980">
<REFERENCE NOTES="&lt;p&gt;Schuster GD, Infante MC. Pain relief after low back surgery: the efficacy of transcutaneous electrical nerve stimulation. Pain 1980 Jun ; 8(3):299-302&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schuster GD, Infante MC</AU>
<TI>Pain relief after low back surgery: the efficacy of transcutaneous electrical nerve stimulation</TI>
<SO>Pain</SO>
<YR>1980</YR>
<VL>8</VL>
<NO>3</NO>
<PG>299-302</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sherry-2001" NAME="Sherry 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sherry E, Kitchener P, Smart R</AU>
<TI>A prospective randomised controlled study of VAX-D and TENS for the treatment of chronic low back pain</TI>
<SO>Neurological Research</SO>
<YR>2001</YR>
<VL>23</VL>
<PG>780-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shimoji-2007" MODIFIED="2008-06-06 12:12:42 -0400" MODIFIED_BY="[Empty name]" NAME="Shimoji 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-06-06 12:12:42 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shimoji K, Takahashi N, Nishio Y, Koyanagi M, Aida S</AU>
<TI>Pain relief by transcutaneous electric nerve stimulation with bidirectional modulated sine waves in patients with chronic back pain: A randomized, double-blind, sham-controlled study</TI>
<SO>Neuromodulation</SO>
<YR>2007</YR>
<VL>10</VL>
<NO>1</NO>
<PG>45-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sternbach-1976" MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NAME="Sternbach 1976" YEAR="1976">
<REFERENCE MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Sternbach RA, Ignelzi RJ, Deems LM, Timmermans G. Transcutaneous Electrical Analgesia: A Follow-Up Analysis. Pain, 1976; 2: 35-41.&lt;/p&gt;" NOTES_MODIFIED="2008-08-13 09:42:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sternbach RA, Ignelzi RJ, Deems LM, Timmermans G</AU>
<TI>Transcutaneous electrical analgesia: A follow-up analysis</TI>
<SO>Pain</SO>
<YR>1976</YR>
<VL>2</VL>
<PG>35-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stonnington-1976" MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NAME="Stonnington 1976" YEAR="1976">
<REFERENCE MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Stonnington HH, Stillwell GK, Ebersold MJ, Thorsteinsson G, Laws ER. Transcutaneous Electrical Stimulation for Chronic Pain Relief: A Pilot Study. Minnesota Medicine 1976; 681-683&lt;/p&gt;" NOTES_MODIFIED="2008-08-13 09:42:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stonnington HH, Stillwell GK, Ebersold MJ, Thorsteinsson G, Laws ER</AU>
<TI>Transcutaneous electrical stimulation for chronic pain relief: A pilot study</TI>
<SO>Minnesota Medicine</SO>
<YR>1976</YR>
<VL>59</VL>
<NO>10</NO>
<PG>681-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thorsteinsson-1978" MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NAME="Thorsteinsson 1978" YEAR="1978">
<REFERENCE MODIFIED="2008-08-13 09:42:48 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Thorsteinsson G, Stonnington HH, Stillwell GK, Elveback LR. The Placebo Effect of Transcutaneous Electrical Stimulation. Pain 1978; 5:31-41.&lt;/p&gt;" NOTES_MODIFIED="2008-08-13 09:42:48 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thorsteinsson G, Stonnington HH, Stillwell GK, Elveback LR</AU>
<TI>The placebo effect of transcutaneous electrical stimulation</TI>
<SO>Pain</SO>
<YR>1978</YR>
<VL>5</VL>
<PG>31-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tsukayama-2002" MODIFIED="2008-06-06 12:14:31 -0400" MODIFIED_BY="[Empty name]" NAME="Tsukayama 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-06-06 12:14:31 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tsukayama H, Yamashita H, Amagai H, Tanno Y</AU>
<TI>Randomised controlled trial comparing the effectiveness of electroacupuncture and TENS for low back pain: A preliminary study for a pragmatic trial</TI>
<SO>Acupuncture in Medicine</SO>
<YR>2002</YR>
<VL>20</VL>
<NO>4</NO>
<PG>175-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Warke-2004" MODIFIED="2008-06-06 12:14:44 -0400" MODIFIED_BY="[Empty name]" NAME="Warke 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-06-06 12:14:44 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Warke K, Al-Smadhi J, Walsh DM, Lowe-Strong AS</AU>
<TI>Use of self-applied TENS for low back pain in people with multiple sclerosis</TI>
<SO>International Journal of Therapy and Rehabilitation</SO>
<YR>2004</YR>
<VL>11</VL>
<NO>6</NO>
<PG>275-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Warke-2006" MODIFIED="2008-06-06 12:14:55 -0400" MODIFIED_BY="[Empty name]" NAME="Warke 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-06-06 12:14:55 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Warke K, Al-Smadi J, Baxter D, Walsh DM, Lowe-Strong AS</AU>
<TI>Efficacy of TENS for chronic low back pain in a multiple sclerosis population: a randomized, placebo-controlled clinical trial</TI>
<SO>The Clinical Journal of Pain</SO>
<YR>2006</YR>
<VL>22</VL>
<NO>9</NO>
<PG>812-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weiner-2003" MODIFIED="2008-08-11 14:52:23 -0400" MODIFIED_BY="[Empty name]" NAME="Weiner 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-08-11 14:52:23 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weiner DK, Rudy TE, Glick RM, Boston JR, Lieber SJ, Morrow LA, Taylor S</AU>
<TI>Efficacy of percutaneous electrical nerve stimulation for the treatment of chronic low back pain in older adults</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>2003</YR>
<VL>51</VL>
<NO>5</NO>
<PG>599-608</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Werners-1999" NAME="Werners 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Werners R, Pynsent PB, Bulstrode CJK</AU>
<TI>Randomized trial comparing interferential therapy with motorized lumbar traction and massage in the management of low back pain in a primary care setting</TI>
<SO>Spine</SO>
<YR>1999</YR>
<VL>24</VL>
<NO>15</NO>
<PG>1579-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yokuyama-2004" MODIFIED="2008-08-11 14:53:27 -0400" MODIFIED_BY="[Empty name]" NAME="Yokuyama 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-08-11 14:53:27 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yokoyama M, Sun X, Oku S, Taga N, Sato K, Mizobuchi S, Takahashi T, Morita Kiyoshi</AU>
<TI>Comparison of percutaneous electrical nerve stimulation with transcutaneous electrical nerve stimulation for long-term relief in patients with chronic low back pain</TI>
<SO>Analgesia and Anesthesia</SO>
<YR>2004</YR>
<VL>98</VL>
<NO>6</NO>
<PG>1552-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Laurent-2008" NAME="Laurent 2008" YEAR="2008">
<REFERENCE PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Laurent B, Navez ML, Nayme P, Joux-Ruesch, Buchmuller A</AU>
<TI>Pain reducing effect of transcutaneous electrical nerve stimulation in patients with chronic low back pain or lumbo-radiculalgia</TI>
<SO>NCT00452010</SO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-04-30 10:13:10 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-08-11 14:42:25 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Andersson-1997" MODIFIED="2008-06-06 11:45:18 -0400" MODIFIED_BY="[Empty name]" NAME="Andersson 1997" TYPE="BOOK_SECTION">
<AU>Andersson GBJ</AU>
<TI>The epidemiology of spinal disorders</TI>
<SO>The adult spine: principles and practice</SO>
<YR>1997</YR>
<PG>93-141</PG>
<EN>2nd</EN>
<ED>J.W. Frymoyer</ED>
<PB>Raven Press, Ltd</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Andersson-1999" NAME="Andersson 1999" TYPE="JOURNAL_ARTICLE">
<AU>Andersson GBJ</AU>
<TI>Epidemiologic features of chronic low-back pain</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>354</VL>
<PG>581-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-APTA-1993" MODIFIED="2008-08-07 12:34:45 -0400" MODIFIED_BY="[Empty name]" NAME="APTA 1993" TYPE="OTHER">
<AU>American Physical Therapy Association</AU>
<TI>American Physical Therapy Association Anthology</TI>
<YR>1993</YR>
<VL>Vol 2</VL>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Barr-1999" MODIFIED="2008-06-06 11:45:34 -0400" MODIFIED_BY="[Empty name]" NAME="Barr 1999" TYPE="BOOK_SECTION">
<AU>Barr JO</AU>
<TI>Transcutaneous Electrical Nerve Stimulation for pain management</TI>
<SO>Clinical electrotherapy</SO>
<YR>1999</YR>
<PG>291-354</PG>
<EN>3rd</EN>
<ED>Nelson RM, Hayes KW, Currier DP</ED>
<PB>Appleton &amp; Lange</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Belanger-2002" NAME="Belanger 2002" TYPE="BOOK">
<AU>Belanger AY</AU>
<SO>Evidence based guide to therapeutic physical agents</SO>
<YR>2002</YR>
<PB>Lippincott Williams &amp; Wilkins</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bombardier-2000" MODIFIED="2008-06-06 12:16:48 -0400" MODIFIED_BY="[Empty name]" NAME="Bombardier 2000" TYPE="JOURNAL_ARTICLE">
<AU>Bombardier C</AU>
<TI>Outcome Assessments in the Evaluation of Treatment of Spinal Disorders: Summary and General Recommendations</TI>
<SO>Spine</SO>
<YR>2000</YR>
<VL>25</VL>
<NO>24</NO>
<PG>3100-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bombardier-2001" MODIFIED="2008-06-06 12:17:19 -0400" MODIFIED_BY="[Empty name]" NAME="Bombardier 2001" TYPE="JOURNAL_ARTICLE">
<AU>Bombardier C, Hayden J, Beaton DE</AU>
<TI>Minimally Clinically Important Difference: low back pain: outcome measures</TI>
<SO>Journal of Rheumatology</SO>
<YR>2001</YR>
<VL>28</VL>
<PG>431-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chou-2007a" MODIFIED="2008-08-11 14:36:31 -0400" MODIFIED_BY="[Empty name]" NAME="Chou 2007a" TYPE="JOURNAL_ARTICLE">
<AU>Chou R, Qaseem R, Snow V, Casey D, Cross JT, Shekelle P, Owens DK</AU>
<TI>Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2007</YR>
<VL>147</VL>
<PG>478-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chou-2007b" NAME="Chou 2007b" TYPE="JOURNAL_ARTICLE">
<AU>Chou R, Huffman LH</AU>
<TI>Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society - American College of Physicians clinical practice guideline</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2007</YR>
<VL>147</VL>
<PG>492-504</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cohen-1988" MODIFIED="2008-06-09 10:25:27 -0400" MODIFIED_BY="[Empty name]" NAME="Cohen 1988" TYPE="BOOK">
<AU>Cohen J</AU>
<SO>Statistical power analysis for the behavioural sciences</SO>
<YR>1988</YR>
<EN>2nd</EN>
<PB>Lawrence Erlbaum Associates</PB>
<CY>Hillsdale, NJ</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coste-1989" MODIFIED="2008-08-11 14:26:05 -0400" MODIFIED_BY="[Empty name]" NAME="Coste 1989" TYPE="JOURNAL_ARTICLE">
<AU>Coste J, Paolaggi JB</AU>
<TI>Critical review of the epidemiology of backache</TI>
<TO>Revue critique de l'épidémiologie des lombalgies</TO>
<SO>Revue D'épidémiologie et de Santé Publique</SO>
<YR>1989</YR>
<VL>37</VL>
<PG>371-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Davidson-2002" MODIFIED="2008-06-09 10:47:24 -0400" MODIFIED_BY="[Empty name]" NAME="Davidson 2002" TYPE="JOURNAL_ARTICLE">
<AU>Davidson M, Keating JL</AU>
<TI>A comparison of five low back pain disability questionnaires: reliability and responsiveness</TI>
<SO>Physical therapy</SO>
<YR>2002</YR>
<VL>82</VL>
<NO>1</NO>
<PG>8-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Delitto-1993" NAME="Delitto 1993" TYPE="JOURNAL_ARTICLE">
<AU>Delitto A, Cibulka MT, Erhard RE, Bowling RW, Tenhula JA</AU>
<TI>Evidence for use of an extension-mobilization category in acute low back syndrome: a prescriptive validation pilot study</TI>
<SO>Physical Therapy</SO>
<YR>1993</YR>
<VL>73</VL>
<PG>216-28</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deveraux-2004" NAME="Deveraux 2004" TYPE="JOURNAL_ARTICLE">
<AU>Deveraux MW</AU>
<TI>Low Back Pain</TI>
<SO>Primary Care: Clinics in Office Practice</SO>
<YR>2004</YR>
<VL>31</VL>
<PG>33-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deyo-1987a" MODIFIED="2008-06-06 11:45:50 -0400" MODIFIED_BY="[Empty name]" NAME="Deyo 1987a" TYPE="JOURNAL_ARTICLE">
<AU>Deyo RA, Tsui-Wu YJ</AU>
<TI>Descriptive epidemiology of low-back pain and its related medical care in the United States</TI>
<SO>Spine</SO>
<YR>1987</YR>
<VL>12</VL>
<PG>264-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deyo-1987b" MODIFIED="2008-06-06 11:45:54 -0400" MODIFIED_BY="[Empty name]" NAME="Deyo 1987b" TYPE="JOURNAL_ARTICLE">
<AU>Deyo RA, Tsui-Wu YJ</AU>
<TI>Functional disability due to low-back pain</TI>
<SO>Arthritis Rheumatism</SO>
<YR>1987</YR>
<VL>30</VL>
<PG>1247-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deyo-1998" MODIFIED="2008-08-11 14:40:56 -0400" MODIFIED_BY="[Empty name]" NAME="Deyo 1998" TYPE="JOURNAL_ARTICLE">
<AU>Deyo R, Battie M, Beurskens A, Bombardier C, Croft P, Koes B, Malmivaara A, Roland M, Von Korff M, Waddell G</AU>
<TI>Outcome Measures for Low Back Pain Research: a proposal for standardized use</TI>
<SO>Spine</SO>
<YR>1998</YR>
<VL>23</VL>
<NO>18</NO>
<PG>2003-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deyo-2001" NAME="Deyo 2001" TYPE="JOURNAL_ARTICLE">
<AU>Deyo RA, Weinstein JN</AU>
<TI>Low back pain</TI>
<SO>New England Journal of Medicine</SO>
<YR>2001</YR>
<VL>344</VL>
<NO>5</NO>
<PG>363-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deyo-2006" MODIFIED="2008-06-06 12:22:37 -0400" MODIFIED_BY="[Empty name]" NAME="Deyo 2006" TYPE="JOURNAL_ARTICLE">
<AU>Deyo R, Mirza S, Martin BI</AU>
<TI>Back pain prevalence and visit rates: estimates from US national surveys, 2002</TI>
<SO>Spine</SO>
<YR>2006</YR>
<VL>31</VL>
<NO>23</NO>
<PG>2724-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Flowerdew-1997" NAME="Flowerdew 1997" TYPE="JOURNAL_ARTICLE">
<AU>Flowerdew MW, Gadsby JG</AU>
<TI>A review of the treatment of chronic low back pain with acupuncture-like transcutaneous electrical stimulation and transcutaneous electrical nerve stimulation</TI>
<SO>Complementary Therapies in Medicine</SO>
<YR>1997</YR>
<VL>5</VL>
<PG>193-201</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gadsby-2000" MODIFIED="2008-06-06 12:26:05 -0400" MODIFIED_BY="[Empty name]" NAME="Gadsby 2000" TYPE="COCHRANE_REVIEW">
<AU>Gadsby JG, Flowerdew MW</AU>
<TI>Transcutaneous electrical nerve stimulation and acupuncture-like transcutaneous like nerve stimulation for chronic low back pain</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2000</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2008-06-06 12:26:05 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-06-06 12:26:05 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000210.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hagg-2003" NAME="Hagg 2003" TYPE="JOURNAL_ARTICLE">
<AU>Hagg O, Fritzell P, Nordwall A</AU>
<TI>The clinical importance of changes in outcome scores after treatment for chronic low back pain</TI>
<SO>European Spine Journal</SO>
<YR>2003</YR>
<VL>12</VL>
<PG>12-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Han-1991" MODIFIED="2008-06-06 11:46:34 -0400" MODIFIED_BY="[Empty name]" NAME="Han 1991" TYPE="JOURNAL_ARTICLE">
<AU>Han JS, Chen XH, Sun SL</AU>
<TI>Effect of low- and high frequency TENS on metenkephalin-Arg-Phe and dynorphin: an immunoreactivity in human lumbar CSF</TI>
<SO>Pain</SO>
<YR>1991</YR>
<VL>47</VL>
<PG>295-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Haynes-1994" NAME="Haynes 1994" TYPE="JOURNAL_ARTICLE">
<AU>Haynes RB, Wilczynski N, McKibbon KA, Walker CJ, Sinclair JC</AU>
<TI>Developing optimal search strategies for detecting clinically sound studies in MEDLINE</TI>
<SO>Journal of the American Medical Informatics Association</SO>
<YR>1994</YR>
<VL>1</VL>
<NO>6</NO>
<PG>447-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Henneken-1987" MODIFIED="2008-06-06 11:46:00 -0400" MODIFIED_BY="[Empty name]" NAME="Henneken 1987" TYPE="BOOK">
<AU>Henneken C, Buring J</AU>
<SO>Epidemiology in Medicine</SO>
<YR>1987</YR>
<PB>Little Brown &amp; Company</PB>
<CY>Boston</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2006" MODIFIED="2008-08-11 14:26:59 -0400" MODIFIED_BY="[Empty name]" NAME="Higgins 2006" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook of Systematic Reviews for Interventions, Version 4.2.6 [updated September 2006]</TI>
<SO>The Cochrane Library</SO>
<YR>2006</YR>
<NO>4</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<CY>Chichester, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hildebrandt-2004" MODIFIED="2008-08-11 14:36:36 -0400" MODIFIED_BY="[Empty name]" NAME="Hildebrandt 2004" TYPE="OTHER">
<AU>Hidebrandt J, Ursin H, Mannion AF, Aireksinin O, Brox JI, Cedraschi C et al. (COST B13 working group on guidelines for chronic low back pain)</AU>
<TI>European guidelines for the management of chronic non-specific low back pain</TI>
<SO>www. backpaineurope.org/web/files/WG2_Guidelines.pdf</SO>
<YR>November 2004 (accessed Jan 2008)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hughes-1984" NAME="Hughes 1984" TYPE="JOURNAL_ARTICLE">
<AU>Hughes GS, Lichstein PR, Whitlock D, Harker C</AU>
<TI>Response of plasma beta-endorphins to transcutaneous electrical stimulation in healthy subjects</TI>
<SO>Physical Therapy</SO>
<YR>1984</YR>
<VL>64</VL>
<PG>1062-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnson-1991a" MODIFIED="2008-06-09 10:34:58 -0400" MODIFIED_BY="[Empty name]" NAME="Johnson 1991a" TYPE="JOURNAL_ARTICLE">
<AU>Johnson MI, Ashton CH, Thompson JW</AU>
<TI>The consistency of pulse frequencies and pulse patterns of transcutaneous electrical nerve stimulation (TENS) used by chronic pain patients</TI>
<SO>Pain</SO>
<YR>1991</YR>
<VL>44</VL>
<NO>3</NO>
<PG>231-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnson-1991b" MODIFIED="2008-06-09 10:35:11 -0400" MODIFIED_BY="[Empty name]" NAME="Johnson 1991b" TYPE="JOURNAL_ARTICLE">
<AU>Johnson MI, Ashton CH, Thompson JW</AU>
<TI>An in-depth study of long-term users of transcutaneous electrical nerve stimulation (TENS). Implications for clinical use of TENS</TI>
<SO>Pain</SO>
<YR>1991</YR>
<VL>44</VL>
<NO>3</NO>
<PG>221-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kalra-2001" NAME="Kalra 2001" TYPE="JOURNAL_ARTICLE">
<AU>Kalra A, Urban MO, Sluka KA</AU>
<TI>Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical stimulation (TENS)</TI>
<SO>JPET</SO>
<YR>2001</YR>
<VL>298</VL>
<PG>257-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Maher-2004" NAME="Maher 2004" TYPE="JOURNAL_ARTICLE">
<AU>Maher CG</AU>
<TI>Effective physical treatment for chronic low back pain</TI>
<SO>Orthopedic Clinics of North America</SO>
<YR>2004</YR>
<VL>35</VL>
<NO>1</NO>
<PG>57-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Melzack-1965" MODIFIED="2008-06-06 11:46:41 -0400" MODIFIED_BY="[Empty name]" NAME="Melzack 1965" TYPE="JOURNAL_ARTICLE">
<AU>Melzack R, Wall PD</AU>
<TI>Pain Mechanisms: a new theory</TI>
<SO>Science</SO>
<YR>1965</YR>
<VL>150</VL>
<PG>971-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Melzack-1982" MODIFIED="2008-06-06 11:46:45 -0400" MODIFIED_BY="[Empty name]" NAME="Melzack 1982" TYPE="BOOK">
<AU>Melzack R, Wall PD</AU>
<SO>The challenge of pain</SO>
<YR>1982</YR>
<PB>Penguin Books Ltd</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Montori-2000" MODIFIED="2008-06-06 12:41:05 -0400" MODIFIED_BY="[Empty name]" NAME="Montori 2000" TYPE="JOURNAL_ARTICLE">
<AU>Montori VM, Smiega M, Guyatt GH</AU>
<TI>Publication bias: a brief review for clinicians</TI>
<SO>Mayo Clinic Proceedings</SO>
<YR>2000</YR>
<VL>75</VL>
<PG>1284-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Muller-2006" NAME="Muller 2006" TYPE="JOURNAL_ARTICLE">
<AU>Muller U, Roder C, Greenough CG</AU>
<TI>Back related outcome instruments</TI>
<SO>European Spine Journal</SO>
<YR>2006</YR>
<VL>15</VL>
<PG>s25-s31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ostelo-2005" MODIFIED="2008-06-06 12:41:39 -0400" MODIFIED_BY="[Empty name]" NAME="Ostelo 2005" TYPE="JOURNAL_ARTICLE">
<AU>Ostelo RWJ , de Vet HCW</AU>
<TI>Clinically important outcomes in low back pain</TI>
<SO>Best practice &amp; research in clinical rheumatology</SO>
<YR>2005</YR>
<VL>19 (4)</VL>
<PG>693-707</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ostelo-2008" MODIFIED="2008-08-11 14:42:25 -0400" MODIFIED_BY="[Empty name]" NAME="Ostelo 2008" TYPE="JOURNAL_ARTICLE">
<AU>Ostelo RWJG, Deyo RA, Stratford P, Waddell G, Croft P, Von Korff M, Bouter LM, de Vet HC</AU>
<TI>Interpreting change scores for pain and functional status in low back pain: Towards international consensus regarding minimally important change</TI>
<SO>Spine</SO>
<YR>2008</YR>
<VL>33</VL>
<NO>1</NO>
<PG>90-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ottenbacher-1995" MODIFIED="2008-06-06 12:42:41 -0400" MODIFIED_BY="[Empty name]" NAME="Ottenbacher 1995" TYPE="JOURNAL_ARTICLE">
<AU>Ottenbacher KJ</AU>
<TI>Why rehabilitation research does not work (As well as we think it should)</TI>
<SO>Arch Phys Med Rehabil</SO>
<YR>1995</YR>
<VL>76</VL>
<PG>123-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-PEDro" MODIFIED="2008-06-06 12:50:56 -0400" MODIFIED_BY="[Empty name]" NAME="PEDro" TYPE="OTHER">
<AU>Australian Physiotherapy Association, Cochrane Rehabilitation and Related Therapies Field, School of Physiotherapy of the University of Sydney</AU>
<TI>PEDro: Physiotherapy Evidence Database</TI>
<SO>http://ptwww.cchs.usyd.edu (accessed July 2007)</SO>
<IDENTIFIERS MODIFIED="2008-06-06 12:49:19 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-06-06 12:49:19 -0400" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE=""/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Pengel-2003" MODIFIED="2008-06-09 10:47:13 -0400" MODIFIED_BY="[Empty name]" NAME="Pengel 2003" TYPE="JOURNAL_ARTICLE">
<AU>Pengel LHM, Herbert RD, Maher CG, Refshauge KM</AU>
<TI>Acute low back pain: systematic review of its prognosis</TI>
<SO>British Medical Journal</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>323-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Petitti-1994" NAME="Petitti 1994" TYPE="BOOK">
<AU>Petitti D</AU>
<SO>Meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine</SO>
<YR>1994</YR>
<PB>Oxford University Press</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Philadelphia-Panel-2001" MODIFIED="2008-08-07 13:48:11 -0400" MODIFIED_BY="[Empty name]" NAME="Philadelphia Panel 2001" TYPE="JOURNAL_ARTICLE">
<AU>Philadelphia Panel</AU>
<TI>Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for low back pain</TI>
<SO>Phys Ther</SO>
<YR>2001</YR>
<VL>81</VL>
<NO>10</NO>
<PG>1641-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-QTF-1987" MODIFIED="2008-06-06 11:47:12 -0400" MODIFIED_BY="[Empty name]" NAME="QTF 1987" TYPE="JOURNAL_ARTICLE">
<AU>Québec Task Force on Spinal Disorders</AU>
<TI>Scientific approach to the assessment and management of activity-related spinal disorder: a monograph for clinicians</TI>
<SO>Spine</SO>
<YR>1987</YR>
<VL>12</VL>
<PG>51-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rushton-2002" NAME="Rushton 2002" TYPE="JOURNAL_ARTICLE">
<AU>Rushton DN</AU>
<TI>Electrical stimulation in the treatment of pain</TI>
<SO>Disability and Rehabilitation</SO>
<YR>2002</YR>
<VL>24</VL>
<NO>8</NO>
<PG>407-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Salar-1981" MODIFIED="2008-06-06 11:47:19 -0400" MODIFIED_BY="[Empty name]" NAME="Salar 1981" TYPE="JOURNAL_ARTICLE">
<AU>Salar G, Job I, Mingrino S, Bosio A, Trabucchi M</AU>
<TI>Effect of transcutaneous electrotherapy on CSF B-endorphin content in patients without pain problems</TI>
<SO>Pain</SO>
<YR>1981</YR>
<VL>10</VL>
<PG>169-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schaufele-2003" NAME="Schaufele 2003" TYPE="JOURNAL_ARTICLE">
<AU>Schaufele MK, Boden SB</AU>
<TI>Outcome research in patients with low back pain</TI>
<SO>Orthopedic Clinics of North America</SO>
<YR>2003</YR>
<VL>34</VL>
<NO>2</NO>
<PG>231-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schlapbach-1991" MODIFIED="2008-06-09 10:38:45 -0400" MODIFIED_BY="[Empty name]" NAME="Schlapbach 1991" TYPE="BOOK_SECTION">
<AU>Schlapbach P, Gerber NJ</AU>
<TI>Rheumatology</TI>
<SO>Physiotherapy: Controlled trials and facts</SO>
<YR>1991</YR>
<VL>14</VL>
<PB>S Karger AG</PB>
<CY>Basel</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sierpina-2002" NAME="Sierpina 2002" TYPE="JOURNAL_ARTICLE">
<AU>Sierpina VS, Curtis P, Doering J</AU>
<TI>An integrative approach to low back pain</TI>
<SO>Clinics in Family Practice</SO>
<YR>2002</YR>
<VL>4</VL>
<NO>4</NO>
<PG>817-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Skovron-1992" MODIFIED="2008-06-06 11:47:34 -0400" MODIFIED_BY="[Empty name]" NAME="Skovron 1992" TYPE="JOURNAL_ARTICLE">
<AU>Skovron ML</AU>
<TI>Epidemiology of low back pain</TI>
<SO>Baillieres Clinical Rheumatologia</SO>
<YR>1992</YR>
<VL>6</VL>
<PG>559-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sluka-1999" NAME="Sluka 1999" TYPE="JOURNAL_ARTICLE">
<AU>Sluka KA, Deacon M, Stibal A, Strissel S, Terpstra A</AU>
<TI>Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats</TI>
<SO>JPET</SO>
<YR>1999</YR>
<VL>289</VL>
<PG>840-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sluka-2003" NAME="Sluka 2003" TYPE="JOURNAL_ARTICLE">
<AU>Sluka KA, Walsh D</AU>
<TI>Transcutaneous electrical nerve stimulation basic science mechanisms and clinical effectiveness</TI>
<SO>Journal of Pain</SO>
<YR>2003</YR>
<VL>4</VL>
<NO>3</NO>
<PG>109-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smeal-2004" MODIFIED="2008-06-06 12:52:59 -0400" MODIFIED_BY="[Empty name]" NAME="Smeal 2004" TYPE="JOURNAL_ARTICLE">
<AU>Smeal WL, Tyburski M, Alleva J, Prather H, Hunt D</AU>
<TI>Conservative management of low back pain. Part I. Discogenic/radicular pain</TI>
<SO>Dis Mon</SO>
<YR>2004</YR>
<VL>50</VL>
<NO>12</NO>
<PG>636-69</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sterne-2001" MODIFIED="2008-06-09 11:38:25 -0400" MODIFIED_BY="[Empty name]" NAME="Sterne 2001" TYPE="JOURNAL_ARTICLE">
<AU>Sterne JAC, Mathias E, Smith GD</AU>
<TI>Investigating and dealing with publication and other biases in meta-analysis</TI>
<SO>BMJ</SO>
<YR>2001</YR>
<VL>323</VL>
<PG>101-105</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tulgar-1991" NAME="Tulgar 1991" TYPE="JOURNAL_ARTICLE">
<AU>Tulgar M, McGlone F, Bowsher D, Miles JB</AU>
<TI>Comparative effectiveness of different stimulation modes in relieving pain. Part II: a double randomized controlled long term clinical trial</TI>
<SO>Pain</SO>
<YR>1991</YR>
<VL>47</VL>
<PG>157-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Van-Tulder-1997" MODIFIED="2008-06-09 11:38:31 -0400" MODIFIED_BY="[Empty name]" NAME="Van Tulder 1997" TYPE="JOURNAL_ARTICLE">
<AU>Van Tulder MW, Koes BW, Bouter LM</AU>
<TI>Conservative treatment of acute and chronic nonspecific low back pain: a systematic review of randomized controlled trials of the most common conservative interventions</TI>
<SO>Spine</SO>
<YR>1997</YR>
<VL>22</VL>
<NO>18</NO>
<PG>2126-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Van-Tulder-1999" MODIFIED="2008-06-06 12:54:14 -0400" MODIFIED_BY="[Empty name]" NAME="Van Tulder 1999" TYPE="BOOK">
<AU>Van Tulder MW, Koes BW, Assendelft WJJ, Bouter LM</AU>
<SO>The effectiveness of conservative treatment of acute and chronic low back pain</SO>
<YR>1999</YR>
<PB>EMGO Institute</PB>
<CY>Amsterdam</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Van-Tulder-2003" NAME="Van Tulder 2003" TYPE="JOURNAL_ARTICLE">
<AU>Van Tulder M, Furlan A, Bombardier C, Bouter L, Editorial Board of of the Cochrane Collaboration Back Review Group</AU>
<TI>Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group</TI>
<SO>Spine</SO>
<YR>2003</YR>
<VL>28</VL>
<NO>12</NO>
<PG>1290-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Von-Korff-1996" NAME="Von Korff 1996" TYPE="JOURNAL_ARTICLE">
<AU>Von Korff M, Saunders K</AU>
<TI>The course of back pain in primary care</TI>
<SO>Spine</SO>
<YR>1996</YR>
<VL>21</VL>
<NO>24</NO>
<PG>2833-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Waddell--1998" NAME="Waddell  1998" TYPE="BOOK_SECTION">
<AU>Waddell G</AU>
<TI>The clinical course of low back pain</TI>
<SO>The back pain revolution</SO>
<YR>1998</YR>
<PG>103-17</PG>
<ED>Waddell G</ED>
<PB>Churchill Livingstone</PB>
<CY>Edinburgh</CY>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2013-04-30 10:13:10 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Brosseau-2002" MODIFIED="2008-06-06 11:48:40 -0400" MODIFIED_BY="[Empty name]" NAME="Brosseau 2002" TYPE="JOURNAL_ARTICLE">
<AU>Brosseau L, Milne S, Robinson V, Marchand S, Shea B, Wells G, et al</AU>
<TI>Efficacy of the Transcutaneous Electrical Nerve Stimulation for the Treatment of Chronic Low Back Pain: A Meta-Analysis</TI>
<SO>Spine</SO>
<YR>2002</YR>
<VL>27</VL>
<NO>6</NO>
<PG>596-03</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Khadilkar-2005" MODIFIED="2008-06-06 13:17:11 -0400" MODIFIED_BY="[Empty name]" NAME="Khadilkar 2005" TYPE="COCHRANE_REVIEW">
<AU>Khadilkar A, Milne S, Brosseau L, Robinson V, Saginur M, Shea B, Tugwell P, Wells G</AU>
<TI>Transcutaneous electrical nerve stimulation (TENS) for chronic low back pain</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2008-06-06 12:56:31 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-06-06 12:56:31 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003008.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Milne-2001" MODIFIED="2008-06-06 13:17:25 -0400" MODIFIED_BY="[Empty name]" NAME="Milne 2001" TYPE="COCHRANE_REVIEW">
<AU>Milne S, Welch V, Brosseau L, Saginur M, Shea B, Tugwell P, et al</AU>
<TI>Transcutaneous electrical nerve stimulation (TENS) for chronic low-back pain</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2008-06-06 11:49:15 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-06-06 11:49:15 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003008."/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Odebiyi-2013" MODIFIED="2013-04-30 10:13:10 -0400" MODIFIED_BY="[Empty name]" NAME="Odebiyi 2013" TYPE="COCHRANE_PROTOCOL">
<AU>Odebiyi DO, Henschke N, Chesterton L, Ferreira ML, Tella A</AU>
<TI>Transcutaneous electrical nerve stimulation (TENS) for chronic low-back pain</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2013-04-30 10:11:06 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-04-30 10:10:58 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD010500"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-08-11 12:18:49 -0400" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-08-11 12:18:49 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-08-08 11:59:35 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cheing-1996">
<CHAR_METHODS MODIFIED="2008-08-06 16:15:57 -0400" MODIFIED_BY="[Empty name]">
<P>Randomized, placebo-controlled trial, parallel design<BR/>Participants stratified by gender, duration of pain and severity of pain prior to randomization<BR/>Sample size: N = 30 (group 1: N = 15, group 2: N = 15); after 8 dropouts and withdrawals, 22 subjects remained (group 1: N = 11; group 2: N = 11)<BR/>Treatment duration: two weeks (data for 1st treatment session reported in 1999 journal article, data at the end of two weeks reported in 1996 abstract)<BR/>No follow-up reported after the end of the two-week treatment period<BR/>TENS administered by researcher in clinic<BR/>Subjective outcomes measured at home over three days prior to study and, then, in the clinic setting</P>
<P>Note: Exclusion of subjects with prior TENS exposure not specifically reported, prior exposure may affect adequacy of blinding</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-08 11:59:35 -0400" MODIFIED_BY="[Empty name]">
<P>Inclusion: age 18 to 50 years, low-back pain for at least six months, moderate to severe pain (greater than or equal to 30% on Visual Analogue Scale), daily pain, stable flexion reflex capable of being induced by painful electrical stimulus to plantar surface of foot</P>
<P>Exclusion: pregnancy, neuromuscular or neurological disorders, muscle atrophy in the lower extremities, a history of back surgery, a consistent sciatica symptoms, cardiac pacemaker, spondylolisthesis &gt; 1 cm</P>
<P>Mean age: group 1: 34.7±9.1; group 2 28.2 ±7.2<BR/>Pain duration: group 1: 6.3±5.7 yrs; group 2: 5.7±4.3 yrs<BR/>Pain severity (SD): group 1: 40.1 (18.7); group 2: 42.7 (12.2)<BR/>Gender: group 1: four women, eleven men; group 2: five women, ten men</P>
<P>No withdrawals or dropouts up to first treatment session; however, there were a total of eight dropouts/withdrawals (four from each of the two groups) by the end of the two-week treatment period, representing 26.6% of the original sample - two dropouts due to time conflicts, two dropouts due to dislike of experimental pain induction, four dropouts due increase in pain or lack of pain improvement during study period</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-06 16:18:03 -0400" MODIFIED_BY="[Empty name]">
<P>Group 1: TENS<BR/>Group 2: Placebo TENS</P>
<P>TENS device: Staodyn MAXIMA III generating continuous trains of biphasic square pulses<BR/>Stimulation mode: Conventional TENS<BR/>Frequency: 80 Hz<BR/>Pulse Width: 140 &#956;sec<BR/>Amplitude: adjusted to produce tingling sensation at two to three times above sensory threshold<BR/>Electrode Placement: two surface electrodes (16.5 cm X 3.2 cm each) were placed over the lumbosacral area (L4-S2) paraspinally</P>
<P>Treatment schedule: 60 minutes/day for five days/week over two weeks (only data for first treatment session reported in 1999 journal article)<BR/>Total treatment time: 600 minutes (10 hours)</P>
<P>Concurrent treatment: participants were required to discontinue physiotherapy or pain medication two weeks before day of treatment</P>
<P>Subjects in both experimental and control groups were told that they might or might not perceive the electrical stimulation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain Intensity (20-cm visual analogue scale) - measured three times a day, over three consecutive days prior to starting treatment to determine baseline </P>
<P>Additional statistical data not reported in the abstract was obtained from the primary authors with VAS scores converted to a 100mm scale.</P>
<P>No report of presence or absence of adverse effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-06-09 11:20:29 -0400" MODIFIED_BY="[Empty name]">
<P>Quality 6/11<BR/>see Table 1 for questions</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-11 12:05:16 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Deyo-1990a">
<CHAR_METHODS MODIFIED="2008-08-11 12:03:06 -0400" MODIFIED_BY="[Empty name]">
<P>Randomized, double-blind, placebo-controlled, parallel design<BR/>Sample size: N = 145; after 20 withdrawals and dropouts, 125 subjects remained (group 1: N = 31; group 2: N = 34; group 3: N = 31; group 4: N = 29)<BR/>Treatment duration: four weeks<BR/>Follow-up at two weeks and two months post-treatment (raw data not reported)<BR/>TENS was self-administered at home<BR/>Subjective outcomes measured in the clinic setting</P>
<P>Note: Subjects with prior exposure to TENS were excluded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-08 11:59:36 -0400" MODIFIED_BY="[Empty name]">
<P>Inclusion: low-back pain longer than three months</P>
<P>Exclusion: history of cancer, use of corticosteroids/anticoagulant, maximal pain above T12, age over 70 years or under 18 years, cardiac pacemaker, known heart disease, severe coexisting disease, previous unevaluated neurologic deficit, previous use of TENS, seeking or receiving disability compensation, factors that would impair follow-up (plan to move within three months, inability to speak English, inaccessibility by telephone, inability to keep twice-weekly appointments)</P>
<P>Mean age : total sample = 51.4 (group 1 = 53.7, group 2 = 53, group 3 = 48.1, group 4 = 50.6)<BR/>Mean VAS score: total sample = 41.3; group 1 = 39.9; group 2 = 43.1; group 3 = 37.9; group 4 = 44.2<BR/>Median pain duration (months): total sample = 60; group 1 = 84; group 2 = 66; group 3 = 60; group 4 = 36<BR/>% females: total = 58, group 1 = 58, group 2 = 59, group 3 = 58, group 4 = 59</P>
<P>Withdrawals and dropouts: 20 dropped out representing 14% of the sample (five from group 1; three from group 2; five from group 3; seven from group 4) - eleven dropouts were due to inconvenience and difficulties with transportation, one dropped out because of impression that treatments were of no help, one subject randomized to sham TENS developed severe dermatitis requiring discontinuation of treatment after four days; reasons for other dropouts not specified)</P>
<P>By the two-month follow-up, there were three further dropouts, representing an additional 2% of the sample.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-11 12:05:16 -0400" MODIFIED_BY="[Empty name]">
<P>Group 1: TENS<BR/>Group 2: TENS + exercise (12 sequential exercises: three relaxation exercises followed by nine stretching exercises for flexibility of spine, hip, lower extremities)<BR/>Group 3: no exercise + sham TENS<BR/>Group 4: sham TENS + exercise</P>
<P>TENS device: Epix 982 units<BR/>Stimulation modes: Conventional TENS for first two weeks, then Conventional TENS or Acupuncture-like TENS for next two weeks depending on patient preference (23% chose to continue using Conventional TENS till the end of the study)<BR/>Average Pulse Frequency: Conventional TENS: 80 to 100 Hz, Acupuncture-like TENS: 2 to 4 Hz; note that a modulated-pulse-rate mode was used in which the rate of stimulation was periodically altered to reach the specified average frequency.<BR/>Pulse Width: not available<BR/>Amplitude: Conventional TENS: 30 (units not reported); Acupuncture-like TENS: 100 (units not reported)<BR/>Electrode placement: four electrodes (5.5 cm in diameter) were initially placed over the area of most severe pain, but were then moved as necessary to optimize pain relief; in sciatica, electrodes were placed on leg and back</P>
<P>Duration of each treatment session: 45 minutes<BR/>Schedule of treatment sessions: three sessions/day for four weeks<BR/>Cumulative application time: 3780 min (63 hours)</P>
<P>Concurrent treatments: hot packs and electric heating pads; written and oral advice for lifting, standing, resting positions; usual pain medications continued; no restriction on use of new medications or physical therapy during study</P>
<P>Subjects were told that the electrical stimulation was sometimes below the threshold of perception and that they might or might not perceive it; placebo units had "on" lights that flashed at the selected frequency.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-06 16:22:48 -0400" MODIFIED_BY="[Empty name]">
<P>Pain (10 cm visual analogue scale used to measure pain intensity and improvement, six-point scale was also used to measure self-rated improvement)<BR/>Functional status (modified Sickness Impact Profile, Self-Rated activity)<BR/>Physical measures (finger-to-floor distance, Schober test, Straight Leg Raise)<BR/>Use of medical services (days in hospital, visits to other providers)<BR/>Data for TENS and placebo TENS reported as adjusted means after controlling for baseline values and the effect of exercise</P>
<P>Data at two-month follow-up not provided in sufficient detail to permit analysis for that time period</P>
<P>Adverse effects: skin irritation at the site of electrode placement was reported in a third of subjects (equal proportions affected in the TENS and sham TENS groups); one subject receiving sham TENS was required to withdraw due to the development of severe dermatitis four days after therapy</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Quality: 8/11<BR/>see Table 1 for questions</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-11 12:18:49 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jarzem-2005a">
<CHAR_METHODS MODIFIED="2008-08-06 16:23:41 -0400" MODIFIED_BY="[Empty name]">
<P>Randomized , placebo-controlled, parallel design<BR/>Sample size : N = 350; after 26 withdrawals, 324 subjects remained (group 1: N = 84; group 2: N = 84; group 3: N = 78; group 4: N = 79)<BR/>Treatment duration: four weeks<BR/>Follow-up: three months (outcomes not reported)<BR/>TENS administered by subjects at home; outcomes measured at home and in the clinic setting</P>
<P>Subjects with prior TENS exposure were excluded<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-11 12:18:49 -0400" MODIFIED_BY="[Empty name]">
<P>Inclusion: Continuous low-back pain without leg symptoms for at least three months; age between 18 and 70; able to make all required visits</P>
<P>Exclusion: Maximal pain above T12; previous use of TENS; patient currently seeking to obtain disability compensation; history of cancer; corticosteroids or anticoagulant use; implanted pacemaker; sciatica; concomitant physiotherapy or chiropractic therapy; recent surgery in the previous three months; onset of major illness; pregnancy</P>
<P>Age: total sample = 45.1<BR/>Pain duration in years: total sample = 10.1 (Group 1 = 10.1; group 2: 9.0; group 3 = 9.4; group 4 = 12.2)<BR/>Baseline pain intensity not reported<BR/>Gender breakdown: 50% female, 50% male</P>
<P>Withdrawals and dropouts: 26 withdrawals (7.4% of sample) due to inability to return to clinic for all evaluation sessions; distribution of dropouts according to treatment group was not reported; note that only 70% returned questionnaires and diaries at the three-months follow-up (data contained in the questionnaires and diaries were not reported)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-11 12:06:21 -0400" MODIFIED_BY="[Empty name]">
<P>Group 1: Placebo TENS<BR/>Group 2: Conventional TENS<BR/>Group 3: Acupuncture-like TENS<BR/>Group 4: NuWave TENS (not considered in this review)</P>
<P>TENS device not reported<BR/>Stimulation parameters not reported<BR/>Electrode number and size not reported<BR/>Electrode placement: adjusted to the patient's preference<BR/>Treatment schedule: daily treatment for four weeks, average of 188 minutes of use per day<BR/>Total treatment time: 5264 minutes or about 88 hours</P>
<P>Concurrent treatment: exercise programs were assigned by physiotherapists to all subjects; medication use was monitored; subjects undergoing other physiotherapy or chiropractic therapy were excluded</P>
<P>The placebo TENS devices had indicator lights to mimic operation; all subjects were told that some might or might not feel the stimulation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-06 16:24:31 -0400" MODIFIED_BY="[Empty name]">
<P>Roland-Morris Disability Questionnaire<BR/>McGill work scale<BR/>McGill activity scale<BR/>Zung depression scale<BR/>Physical measures (flexion, extension, straight leg raise, isometric dead-lift score)</P>
<P>Patient Diaries tracking pain intensity (VAS), frequency of pain medication usage, ancillary care, general medical concerns and usage of the TENS unit<BR/>were not returned in 30% of cases and the data was not reported</P>
<P>Outcomes not reported at three months follow-up (30% loss to follow-up)</P>
<P>No reporting of adverse effects<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Quality 8/11<BR/>See Table 1 for questions<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-11 12:09:50 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Topuz-2004">
<CHAR_METHODS MODIFIED="2008-08-11 12:06:42 -0400" MODIFIED_BY="[Empty name]">
<P>Randomized, placebo-controlled trial, parallel design<BR/>Sample size: N = 60; after five dropouts, 55 subjects remained (group 1: N = 12; group 2: N = 15; group 3: N = 15; group 4: N = 13)<BR/>Treatment duration: two weeks<BR/>No follow-up<BR/>TENS administered by researcher in clinic</P>
<P>Subjects with prior TENS exposure were excluded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-08-11 12:06:55 -0400" MODIFIED_BY="[Empty name]">
<P>Inclusion: low-back pain for at least three months and ambulatory</P>
<P>Exclusion: history of cancer; use of corticosteroids or anticoagulants; use of cardiac pacemaker; prior lumbar spine surgery; known heart disease; severe co-existing disease; vertebral fracture; spinal infection; spinal tumour; severe orthopedic abnormalities; nerve root findings; previous use of a therapeutic electrical stimulation modality</P>
<P>Mean age (SD): group 1 = 41.92 (7.70); group 2 = 45.20 (11.19); group 3 = 50.13 (11.97)<BR/>Pain severity (SD): group 1 = 5.75 (1.35); group 2 = 6.53 (1.18); group 3 = 6.86 (1.24)<BR/>Pain duration in months (SD): group 1 = 16.81 (8.75); group 2 = 16.46 (9.78); group 3 = 20.53 (14.42)<BR/>Gender (% female): group 1 = 91.7%; group 2 = 60%; group 3 = 73.3%<BR/>No significant differences in the Beck Depression Inventory between treatment groups</P>
<P>Withdrawals and Dropouts - five dropouts (8.3% of sample) for personal reasons; three of the dropouts were in the Placebo TENS group and two were in the percutaneous neuromodulation therapy group</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-08-11 12:09:50 -0400" MODIFIED_BY="[Empty name]">
<P>Group 1: Placebo TENS<BR/>Group 2: Conventional TENS<BR/>Group 3: Low-frequency TENS<BR/>Group 4: Percutaneous neuromodulation therapy (not considered)</P>
<P>TENS device: Trio 300 units generating symmetric, biphasic, rectangular pulses<BR/>Stimulation modes: Conventional TENS and Low Frequency TENS<BR/>Pulse Frequency: 80Hz for Conventional TENS group; 4Hz for Low-frequency TENS group<BR/>Pulse Width: 100 &#956;sec<BR/>Amplitude: For the conventional TENS group, the amplitude was increased up to the subjects' perception of paresthesia; for the low frequency TENS group, amplitude was increased to a maximum tolerated level without inducing muscle contraction<BR/>Electrode Placement: four electrodes (2x2 cm) were placed in a standard dermatomal pattern over the most painful lumbar region</P>
<P>Treatment duration: 20 minutes per session<BR/>Treatment schedule: five sessions per week for two weeks<BR/>Cumulative stimulation time: 200 minutes or just over three hours</P>
<P>Concurrent treatment: No specific restrictions on the use of analgesic medications, except corticosteroids</P>
<P>Subjects were told that they might or might not perceive the electrical stimulation and that it was sometimes below a patient's threshold of perception<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-08-06 16:26:04 -0400" MODIFIED_BY="[Empty name]">
<P>Pain intensity (10 cm visual analogue scale)<BR/>Activity Pain (10 cm visual analogue scale)<BR/>Oswestry Disability Index<BR/>Low Back Pain Outcome Scale<BR/>Health Status Survey Short Form (SF-36)</P>
<P>No reporting of adverse effects<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Quality: 8/11<BR/>see Table 1 for questions</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-08-11 12:11:25 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2008-08-08 11:59:44 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Al_x002d_Smadi-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-08 11:59:44 -0400" MODIFIED_BY="[Empty name]">
<P>Pilot study involving only five subjects per treatment group; Study sample confined to patients with multiple sclerosis, a chronic inflammatory disorder of the central nervous system. Potential contribution of neuropathic pain (e.g. demyelinating lesions involving the spinal cord) to etiology of low-back symptoms cannot be excluded</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Biedermann-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Trial investigated EMG biofeedback, not TENS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bloodworth-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Sample composed exclusively of patients with chronic, electromyographically-documented lumbosacral radiculopathy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-11 12:10:22 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cheng-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-11 12:10:22 -0400" MODIFIED_BY="[Empty name]">
<P>No appropriate control (TENS versus electroacupuncture)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cubucku-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Most subjects had meralgia paresthetica, a painful neuropathy of the lateral femoral cutaneous nerve</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-11 12:10:27 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fox-1976">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-11 12:10:27 -0400" MODIFIED_BY="[Empty name]">
<P>No appropriate control (TENS versus acupuncture)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-08 11:59:46 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gemignani-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-08 11:59:46 -0400" MODIFIED_BY="[Empty name]">
<P>Mixed sample of acute, subacute, and chronic low-back pain;<BR/>Study confined to subjects with ankylosing spondylitis (inflammatory arthritis)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-06 16:26:57 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ghoname-1999a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-06 16:26:57 -0400" MODIFIED_BY="[Empty name]">
<P>No appropriate control (four modalities were compared: TENS, percutaneous electrical nerve stimulation (PENS), sham PENS, exercise)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-06 16:27:03 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ghoname-1999b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-06 16:27:03 -0400" MODIFIED_BY="[Empty name]">
<P>No appropriate control (three modalities were compared: TENS, PENS, sham PENS); study confined to subjects with sciatica</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-08 11:59:47 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Glaser-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-08 11:59:47 -0400" MODIFIED_BY="[Empty name]">
<P>Mixed sample of subacute and chronic low-back pain; investigation of electrical muscle stimulation, not TENS (subthreshold TENS served as a placebo control)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-11 12:10:41 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Grant-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-11 12:10:41 -0400" MODIFIED_BY="[Empty name]">
<P>No appropriate control (TENS versus acupuncture)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hackett-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention involved electroacupuncture, not TENS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hamza-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Investigation of percutaneous electrical nerve stimulation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-08 11:59:48 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Herman-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-08 11:59:48 -0400" MODIFIED_BY="[Empty name]">
<P>Study included subjects with acute and subacute low-back pain</P>
<P>Mixed sample of subjects with acute, subacute, and chronic low-back pain</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-08 11:59:50 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hsieh-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-08 11:59:50 -0400" MODIFIED_BY="[Empty name]">
<P>Mixed sample of acute, subacute, and chronic low-back pain</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-08 11:59:51 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hurley-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-08 11:59:51 -0400" MODIFIED_BY="[Empty name]">
<P>Subjects had subacute low-back pain (one to three months);<BR/>Intervention involved Interferential therapy, not TENS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jarzem-2005b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Inadequate statistical data</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-08 11:59:52 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jeans-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-08 11:59:52 -0400" MODIFIED_BY="[Empty name]">
<P>Fewer than five patients with chronic low-back pain per study group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-11 12:10:53 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Laitinen-1976">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-11 12:10:53 -0400" MODIFIED_BY="[Empty name]">
<P>No appropriate control (TENS versus acupuncture)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-11 12:10:57 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lampe-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-11 12:10:57 -0400" MODIFIED_BY="[Empty name]">
<P>Duration and location of back pain unclear; no appropriate control (Conventional TENS versus nonstandard, experimental waveform)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lehmann-1983">
<CHAR_REASON_FOR_EXCLUSION>
<P>Inpatient program</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-07-29 15:16:14 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lehmann-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-07-29 15:16:14 -0400" MODIFIED_BY="[Empty name]">
<P>Inpatient program; based on the same trial as <LINK REF="STD-Lehmann-1983" TYPE="STUDY">Lehmann 1983</LINK>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-08 11:59:53 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lundeberg-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-08 11:59:53 -0400" MODIFIED_BY="[Empty name]">
<P>Study involved patients with chronic myalgia for which etiology was not clearly defined; study sample not specifically limited to subjects with chronic low-back pain<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Macdonald-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention involved superficial acupuncture, not TENS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Marchand-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study included subjects with inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis) and other specific diagnoses, for which exact numbers were not provided</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-11 12:11:15 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Melzack-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-11 12:11:15 -0400" MODIFIED_BY="[Empty name]">
<P>No appropriate control (TENS versus ice massage)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-11 12:11:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Melzack-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-11 12:11:18 -0400" MODIFIED_BY="[Empty name]">
<P>No appropriate control (TENS versus massage)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-08 11:59:54 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moore-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-08 11:59:54 -0400" MODIFIED_BY="[Empty name]">
<P>Mixed sample of upper, middle and low-back pain</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pressor-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Trial examined the analgesic effect of TENS on the pain of epidural steroid injection, not chronic back pain itself</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Puranik-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Biophysical parameters used for stimulation not comparable to standard forms of TENS (device known as the Action Potential Stimulator)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rutkowski-1977">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention involved electroacupuncture, not TENS<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schuster-1980">
<CHAR_REASON_FOR_EXCLUSION>
<P>Inpatients; investigation of the relief of postoperative pain following back surgery</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-11 12:11:25 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sherry-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-11 12:11:25 -0400" MODIFIED_BY="[Empty name]">
<P>No appropriate control (TENS versus vertebral axial decompression)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Shimoji-2007">
<CHAR_REASON_FOR_EXCLUSION>
<P>Included patients with pain above L1, at the middle and/or upper back</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sternbach-1976">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized; subjects had chronic pain of multiple etiologies and locations</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-08 11:59:55 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stonnington-1976">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-08 11:59:55 -0400" MODIFIED_BY="[Empty name]">
<P>No appropriate control; pilot study on chronic pain, not specific for chronic low-back pain</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-08 11:59:56 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Thorsteinsson-1978">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-08 11:59:56 -0400" MODIFIED_BY="[Empty name]">
<P>Could not separate data for chronic low-back pain from data for other causes of chronic pain.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-08 11:59:56 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tsukayama-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-08 11:59:56 -0400" MODIFIED_BY="[Empty name]">
<P>No appropriate control (TENS vs electroacupuncture)<BR/>Study sample included subjects with acute low-back pain</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-06 16:28:45 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Warke-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-06 16:28:45 -0400" MODIFIED_BY="[Empty name]">
<P>Duplicate report. Based on the same trial as <LINK REF="STD-Al_x002d_Smadi-2003" TYPE="STUDY">Al-Smadi 2003</LINK>, except with longer follow-up. Only five subjects per treatment group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-08 11:59:58 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Warke-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-08 11:59:58 -0400" MODIFIED_BY="[Empty name]">
<P>Study sample confined to patients with multiple sclerosis, a chronic inflammatory disorder of the central nervous system. Potential contribution of neuropathic pain (e.g. demyelinating lesions involving the spinal cord) to etiology of low-back symptoms cannot be excluded.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Weiner-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study evaluated percutaneous electrical stimulation not TENS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-08 11:59:59 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Werners-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-08 11:59:59 -0400" MODIFIED_BY="[Empty name]">
<P>Mixed sample of acute, subacute and chronic low-back pain;<BR/>Intervention involved Interferential therapy, not TENS; no appropriate control</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Yokuyama-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Head-to-head study comparing percutaneous electrical nerve stimulation to TENS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2008-08-08 12:00:02 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2008-08-08 12:00:02 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Laurent-2008">
<CHAR_STUDY_NAME MODIFIED="2008-08-08 12:00:02 -0400" MODIFIED_BY="[Empty name]">
<P>Pain reducing effect of transcutaneous electrical nerve stimulation in patients with chronic low-back pain or lumbo-radiculalgia</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_STARTING_DATE/>
<CHAR_CONTACT_INFORMATION/>
<CHAR_NOTES/>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2008-08-11 12:05:43 -0400" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2008-06-09 11:18:29 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:02:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheing-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:10:19 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deyo-1990a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:18:29 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jarzem-2005a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:13:07 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Topuz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cheing-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Deyo-1990a">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Jarzem-2005a">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Topuz-2004">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2008-06-09 11:19:55 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.03" NO="3">
<NAME>All outcomes - outcome assessors?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.02" NO="2">
<NAME>All outcomes - providers?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes - patients?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-06-09 11:02:31 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheing-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2008-06-09 11:02:33 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cheing-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2008-06-09 11:19:55 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cheing-1996">
<DESCRIPTION>
<P>Unclear from text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-06-09 11:10:24 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deyo-1990a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2008-06-09 11:19:48 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Deyo-1990a">
<DESCRIPTION>
<P>Unclear from text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2008-06-09 11:10:25 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deyo-1990a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-06-09 11:11:40 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jarzem-2005a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2008-06-09 11:18:02 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jarzem-2005a">
<DESCRIPTION>
<P>Unclear from text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2008-06-09 11:11:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jarzem-2005a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2008-06-09 11:13:12 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Topuz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.02" MODIFIED="2008-06-09 11:13:13 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Topuz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.03" MODIFIED="2008-06-09 11:17:21 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Topuz-2004">
<DESCRIPTION>
<P>Unclear from text</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="GROUP" NO="11">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-12" LEVEL="GROUP" NO="12">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2008-08-11 12:05:43 -0400" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes - drop-outs?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.02" NO="2">
<NAME>All outcomes - ITT analysis?</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-08-06 16:18:55 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cheing-1996">
<DESCRIPTION>
<P>No withdrawals or dropouts up to first treatment session; however, there were a total of eight dropouts/withdrawals (four from each of the two groups) by the end of the two-week treatment period, representing 26.6% of the original sample - two dropouts due to time conflicts, two dropouts due to dislike of experimental pain induction, four dropouts due increase in pain or lack of pain improvement during study period</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2008-06-09 11:09:59 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Cheing-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-08-11 12:05:43 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deyo-1990a">
<DESCRIPTION>
<P>20 dropped out representing 14% of the sample (five from group 1; three from group 2; five from group 3; seven from group 4) - eleven dropouts were due to inconvenience and difficulties with transportation, one dropped out because of impression that treatments were of no help, one subject randomized to sham TENS developed severe dermatitis requiring discontinuation of treatment after four days; reasons for other dropouts not specified)</P>
<P>By the two-month follow-up, there were three further dropouts, representing an additional 2% of the sample.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2008-06-09 11:10:37 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Deyo-1990a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-08-06 16:24:42 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jarzem-2005a">
<DESCRIPTION>
<P>26 withdrawals (7.4% of sample) due to inability to return to clinic for all evaluation sessions; distribution of dropouts according to treatment group was not reported; note that only 70% returned questionnaires and diaries at the three-months follow-up (data contained in the questionnaires and diaries were not reported)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2008-06-09 11:11:53 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jarzem-2005a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2008-08-06 16:26:21 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Topuz-2004">
<DESCRIPTION>
<P>five dropouts (8.3% of sample) for personal reasons; three of the dropouts were in the Placebo TENS group and two were in the percutaneous neuromodulation therapy group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2008-06-09 11:13:22 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Topuz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2008-06-09 11:13:26 -0400" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Similarity of baseline characteristics?</NAME>
<DESCRIPTION>
<P>Were the groups similar at baseline regarding the most important prognostic indicators?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:10:04 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheing-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:10:42 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Deyo-1990a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:11:57 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jarzem-2005a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:13:26 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Topuz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="STUDY" MODIFIED="2008-06-09 11:13:30 -0400" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Co-interventions avoided or similar?</NAME>
<DESCRIPTION>
<P>Were co-interventions avoided or similar?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:10:08 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheing-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:10:45 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deyo-1990a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:12:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jarzem-2005a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:13:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Topuz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2008-06-09 11:13:30 -0400" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Compliance acceptable?</NAME>
<DESCRIPTION>
<P>Was the compliance acceptable in all groups?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:10:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheing-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:10:47 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deyo-1990a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:12:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jarzem-2005a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:13:30 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Topuz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2008-06-09 11:13:37 -0400" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Timing outcome assessments similar?</NAME>
<DESCRIPTION>
<P>Was the timing of the outcome assessment in all groups similar?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:10:14 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cheing-1996">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:10:53 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deyo-1990a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:12:05 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jarzem-2005a">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-06-09 11:13:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Topuz-2004">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-08-11 12:12:14 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2008-08-11 12:12:14 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-08-11 12:12:14 -0400" MODIFIED_BY="[Empty name]">Criteria for Assessment of Methodological Quality</TITLE>
<TABLE COLS="1" ROWS="1">
<TR>
<TD>
<P>
<I>
<B>Was the method of randomisation adequate?</B>
</I>  A random (unpredictable) assignment sequence. Examples of adequate methods are computer-generated random numbers table and use of sealed opaque envelopes. Methods of allocation using date of birth, date of admission, hospital numbers, or alternation should not be regarded as appropriate.</P>
<P>
<I>
<B>Was the treatment allocation concealed?</B>
</I>  Assignment generated by an independent person not responsible for determining the eligibility of the patients. This person has no information about the persons included in the trial and has no influence on the assignment sequence or on the decision about eligibility of the patient.</P>
<P>
<I>
<B>Was the patient blinded to the intervention?</B>
</I> The review author determines if enough information about the blinding is given in order to score a "yes." </P>
<P>
<I>
<B>Was the care provider blinded to the intervention?</B>
</I> The review author determines if enough information about the blinding is given in order to score a "yes." </P>
<P>
<I>
<B>Was the outcome assessor blinded to the intervention?</B>
</I> The review author determines if enough information about the blinding is given in order to score a "yes." </P>
<P>
<I>
<B>Was the drop-out rate described and acceptable?</B>
</I> The number of participants who were included in the study but did not complete the observation period or were not included in the analysis must be described and reasons given. If the percentage of withdrawals and drop-outs does not exceed 20% for immediate and short-term follow-ups, 30% for intermediate and long-term follow-ups and does not lead to substantial bias a "yes" is scored. </P>
<P>
<I>
<B>Did the analysis include an intention-to-treat analysis?</B>
</I> All randomized patients are reported/analyzed in the group to which they were allocated by randomization for the most important moments of effect measurement (minus missing values), irrespective of noncompliance and co-interventions.</P>
<P>
<I>
<B>Were the groups similar at baseline regarding the most important prognostic indicators?</B>
</I> In order to receive a "yes," groups have to be similar at baseline regarding demographic factors, duration and severity of complaints, percentage of patients with neurological symptoms, and value of main outcome measure(s).</P>
<P>
<I>
<B>Were co-interventions avoided or similar?</B>
</I> Co-interventions should either be avoided in the trial design or be similar between the index and control groups. </P>
<P>
<I>
<B>Was the compliance acceptable in all groups?</B>
</I> The review author determines if the compliance to the interventions is acceptable, based on the reported intensity, duration, number and frequency of sessions for both the index intervention and control intervention(s). </P>
<P>
<I>
<B>Was the timing of the outcome assessment in all groups similar?</B>
</I> Timing of outcome assessment should be identical for all intervention groups and for all important outcome assessments. </P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-08-11 12:14:32 -0400" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2008-06-09 11:38:52 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Conventional TENS (C-TENS) vs Placebo, end of treatment (2 weeks)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2008-06-09 11:38:52 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="51.03339851969911" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="11" TOTAL_2="11" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain Intensity , VAS (0-100)</NAME>
<GROUP_LABEL_1>Conventional TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours C-TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.432342720461163" CI_START="-26.83234272046117" EFFECT_SIZE="-12.200000000000003" ESTIMABLE="YES" MEAN_1="22.4" MEAN_2="34.6" ORDER="3003" SD_1="19.7" SD_2="15.0" SE="7.465618162312786" STUDY_ID="STD-Cheing-1996" TOTAL_1="11" TOTAL_2="11" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2008-07-04 15:49:39 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Conventional TENS +/- Acupuncture-like TENS vs Placebo, end of treatment (4 weeks)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="65" TOTAL_2="60" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain Intensity, VAS (0-100)</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.949384104268899" CI_START="-9.5493841042689" EFFECT_SIZE="-2.3000000000000007" ESTIMABLE="YES" MEAN_1="21.7" MEAN_2="24.0" ORDER="3004" SD_1="20.66" SD_2="20.66" SE="3.698733324413671" STUDY_ID="STD-Deyo-1990a" TOTAL_1="65" TOTAL_2="60" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2008-06-09 11:39:04 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="20.629186490770028" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="65" TOTAL_2="60" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain Improvement, VAS (0-100)</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="16.951300757597558" CI_START="-6.55130075759755" EFFECT_SIZE="5.200000000000003" ESTIMABLE="YES" MEAN_1="47.0" MEAN_2="41.8" ORDER="3005" SD_1="33.49" SD_2="33.49" SE="5.995671782895152" STUDY_ID="STD-Deyo-1990a" TOTAL_1="65" TOTAL_2="60" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2008-06-09 11:39:17 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.5191426809753259" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="65" TOTAL_2="60" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain Improvement, (1-6, 1=pain entirely gone, 6=much worse)</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.36492543409678874" CI_START="-0.36492543409678874" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="2.9" MEAN_2="2.9" ORDER="3006" SD_1="1.04" SD_2="1.04" SE="0.18618986725025255" STUDY_ID="STD-Deyo-1990a" TOTAL_1="65" TOTAL_2="60" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2008-06-09 11:39:26 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.0041221991425402" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="65" TOTAL_2="60" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Frequency of Pain, (1-5, 1=never, 5=all the time)</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.3000144181445568" CI_START="-0.5000144181445569" EFFECT_SIZE="-0.10000000000000009" ESTIMABLE="YES" MEAN_1="2.9" MEAN_2="3.0" ORDER="3007" SD_1="1.14" SD_2="1.14" SE="0.20409273910123837" STUDY_ID="STD-Deyo-1990a" TOTAL_1="65" TOTAL_2="60" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.05" MODIFIED="2008-06-09 11:39:34 -0400" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.014408001618015" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="65" TOTAL_2="60" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Generic Health Status (Modified Version of Sickness Impact Profile)</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.2509403039836307" CI_START="-2.2509403039836307" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="5.7" MEAN_2="6.2" ORDER="3008" SD_1="4.99" SD_2="4.99" SE="0.8933533053641926" STUDY_ID="STD-Deyo-1990a" TOTAL_1="65" TOTAL_2="60" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.06" MODIFIED="2008-06-09 11:39:44 -0400" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.5191426809753259" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="65" TOTAL_2="60" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Self-Rated Activity Level (1-3, 1=more active than baseline, 3=less active)</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.20000720907227845" CI_START="-0.20000720907227845" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="1.7" ORDER="3009" SD_1="0.57" SD_2="0.57" SE="0.10204636955061919" STUDY_ID="STD-Deyo-1990a" TOTAL_1="65" TOTAL_2="60" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.07" MODIFIED="2008-06-09 11:39:50 -0400" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.014408001618015" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="65" TOTAL_2="60" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Flexion ROM (finger-to-floor distance (cm))</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TENS</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.5509691402727444" CI_START="-2.5509691402727444" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="8.7" MEAN_2="8.7" ORDER="3010" SD_1="7.27" SD_2="7.27" SE="1.3015387835666692" STUDY_ID="STD-Deyo-1990a" TOTAL_1="65" TOTAL_2="60" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.08" MODIFIED="2008-06-09 11:39:58 -0400" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.0041221991425402" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="65" TOTAL_2="60" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Flexion ROM (Schober test (cm))</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TENS</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.4684343325015661" CI_START="-0.268434332501565" EFFECT_SIZE="0.10000000000000053" ESTIMABLE="YES" MEAN_1="4.2" MEAN_2="4.1" ORDER="3011" SD_1="1.05" SD_2="1.05" SE="0.18798015443535113" STUDY_ID="STD-Deyo-1990a" TOTAL_1="65" TOTAL_2="60" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.09" MODIFIED="2008-06-09 11:40:05 -0400" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.014408001618015" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="65" TOTAL_2="60" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Lasegue's SLR (degrees)</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TENS</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.6983428732733707" CI_START="-2.6983428732733707" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="84.0" MEAN_2="84.0" ORDER="3012" SD_1="7.69" SD_2="7.69" SE="1.3767308453408098" STUDY_ID="STD-Deyo-1990a" TOTAL_1="65" TOTAL_2="60" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.10" MODIFIED="2008-07-04 15:49:39 -0400" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.5191426809753259" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="65" TOTAL_2="60" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Use of Medical Services, (visits to other providers)</NAME>
<GROUP_LABEL_1>TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.06035593619107263" CI_START="-0.2203559361910726" EFFECT_SIZE="-0.07999999999999999" ESTIMABLE="YES" MEAN_1="0.22" MEAN_2="0.3" ORDER="3014" SD_1="0.4" SD_2="0.4" SE="0.0716114874039433" STUDY_ID="STD-Deyo-1990a" TOTAL_1="65" TOTAL_2="60" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2008-06-09 11:41:08 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Conventional TENS (C-TENS) vs Placebo, end of treatment (2 weeks)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2008-06-09 11:40:37 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="51.03339851969911" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain Intensity, VAS (0-100)</NAME>
<GROUP_LABEL_1>Conventional TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours C-TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-10.517545448874861" CI_START="-33.082454551125146" EFFECT_SIZE="-21.800000000000004" ESTIMABLE="YES" MEAN_1="37.3" MEAN_2="59.1" ORDER="3015" SD_1="16.2" SD_2="13.7" SE="5.7564601391248535" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2008-06-09 11:40:47 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="51.03339851969911" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Activity Pain, VAS (0-100)</NAME>
<GROUP_LABEL_1>Conventional TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours C-TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-7.0188407296516555" CI_START="-27.381159270348334" EFFECT_SIZE="-17.199999999999996" ESTIMABLE="YES" MEAN_1="48.6" MEAN_2="65.8" ORDER="3016" SD_1="16.8" SD_2="9.9" SE="5.194564466824914" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.03" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Oswestry Disability Index</NAME>
<GROUP_LABEL_1>Conventional TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours C-TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.244365751100604" CI_START="-9.504365751100602" EFFECT_SIZE="-4.129999999999999" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="18.33" ORDER="3017" SD_1="8.88" SD_2="5.21" SE="2.7420737286465027" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.04" MODIFIED="2008-06-09 11:40:55 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="20.629186490770028" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Low Back Pain Outcome Scale</NAME>
<GROUP_LABEL_1>Conventional TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours C-TENS</GRAPH_LABEL_2>
<CONT_DATA CI_END="15.243306403818078" CI_START="-4.003306403818069" EFFECT_SIZE="5.6200000000000045" ESTIMABLE="YES" MEAN_1="58.53" MEAN_2="52.91" ORDER="3018" SD_1="14.36" SD_2="11.15" SE="4.909940427337179" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.05" MODIFIED="2008-06-09 11:41:08 -0400" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="101.52139889878251" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="120" TOTAL_2="96" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Quality of Life (SF-36)</NAME>
<GROUP_LABEL_1>Conventional TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours C-TENS</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.05.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Physical Function</NAME>
<CONT_DATA CI_END="20.89741430497081" CI_START="-8.057414304970804" EFFECT_SIZE="6.420000000000002" ESTIMABLE="YES" MEAN_1="66.0" MEAN_2="59.58" ORDER="3019" SD_1="21.14" SD_2="17.24" SE="7.38657159986959" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.05.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Social Functioning</NAME>
<CONT_DATA CI_END="27.469595988440393" CI_START="-7.889595988440394" EFFECT_SIZE="9.79" ESTIMABLE="YES" MEAN_1="69.16" MEAN_2="59.37" ORDER="3020" SD_1="24.02" SD_2="22.69" SE="9.020367786293416" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.05.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Physical Role Limitations</NAME>
<CONT_DATA CI_END="59.33529910111638" CI_START="3.704700898883619" EFFECT_SIZE="31.519999999999996" ESTIMABLE="YES" MEAN_1="54.44" MEAN_2="22.92" ORDER="3021" SD_1="39.19" SD_2="34.47" SE="14.191739909773805" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.05.04" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Emotional Role Limitations</NAME>
<CONT_DATA CI_END="52.33420377294841" CI_START="5.945796227051584" EFFECT_SIZE="29.14" ESTIMABLE="YES" MEAN_1="62.19" MEAN_2="33.05" ORDER="3022" SD_1="33.02" SD_2="28.43" SE="11.833994887610862" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.05.05" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>General Mental Health</NAME>
<CONT_DATA CI_END="19.347744809715465" CI_START="4.132255190284555" EFFECT_SIZE="11.740000000000009" ESTIMABLE="YES" MEAN_1="70.4" MEAN_2="58.66" ORDER="3023" SD_1="8.91" SD_2="10.83" SE="3.881573778765515" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.05.06" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Vitality</NAME>
<CONT_DATA CI_END="17.69360407861354" CI_START="3.3063959213864607" EFFECT_SIZE="10.5" ESTIMABLE="YES" MEAN_1="71.33" MEAN_2="60.83" ORDER="3024" SD_1="9.15" SD_2="9.73" SE="3.6702736046967037" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.05.07" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Bodily Pain</NAME>
<CONT_DATA CI_END="23.27425979282146" CI_START="-2.2942597928214568" EFFECT_SIZE="10.490000000000002" ESTIMABLE="YES" MEAN_1="54.4" MEAN_2="43.91" ORDER="3025" SD_1="19.05" SD_2="14.84" SE="6.522701383118296" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.05.08" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>General Health Perception</NAME>
<CONT_DATA CI_END="19.975954481414448" CI_START="-2.7359544814144403" EFFECT_SIZE="8.620000000000005" ESTIMABLE="YES" MEAN_1="65.53" MEAN_2="56.91" ORDER="3026" SD_1="17.44" SD_2="12.63" SE="5.793960792641479" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2008-06-09 11:41:54 -0400" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Acupuncture-like TENS (A-TENS) vs Placebo, end of treatment (2 weeks)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2008-06-09 11:41:19 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="51.03339851969911" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain Intensity, VAS (0-100)</NAME>
<GROUP_LABEL_1>A-TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours A-TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-3.5497687872202928" CI_START="-29.450231212779705" EFFECT_SIZE="-16.5" ESTIMABLE="YES" MEAN_1="42.6" MEAN_2="59.1" ORDER="3027" SD_1="20.5" SD_2="13.7" SE="6.607382235045888" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.02" MODIFIED="2008-06-09 11:41:29 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="51.03339851969911" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Activity Pain, VAS (0-100)</NAME>
<GROUP_LABEL_1>A-TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours A-TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.5316685895994961" CI_START="-24.468331410400502" EFFECT_SIZE="-12.5" ESTIMABLE="YES" MEAN_1="53.3" MEAN_2="65.8" ORDER="3028" SD_1="20.9" SD_2="9.9" SE="6.10640374252036" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.03" MODIFIED="2008-06-09 11:41:38 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="20.629186490770028" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Oswestry Disability Index</NAME>
<GROUP_LABEL_1>A-TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours A-TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.615226349199916" CI_START="-10.524773650800082" EFFECT_SIZE="-6.0699999999999985" ESTIMABLE="YES" MEAN_1="12.26" MEAN_2="18.33" ORDER="3029" SD_1="6.6" SD_2="5.21" SE="2.272885464191571" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.04" MODIFIED="2008-06-09 11:41:44 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="20.629186490770028" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Low Back Pain Outcome Scale</NAME>
<GROUP_LABEL_1>A-TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours A-TENS</GRAPH_LABEL_2>
<CONT_DATA CI_END="12.19821411084933" CI_START="-4.298214110849324" EFFECT_SIZE="3.950000000000003" ESTIMABLE="YES" MEAN_1="56.86" MEAN_2="52.91" ORDER="3030" SD_1="10.5" SD_2="11.15" SE="4.208349834951146" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.05" MODIFIED="2008-06-09 11:41:54 -0400" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="101.52139889878251" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="120" TOTAL_2="96" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Quality of Life (SF-36)</NAME>
<GROUP_LABEL_1>A-TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours A-TENS</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.05.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Physical Function</NAME>
<CONT_DATA CI_END="19.571515458567376" CI_START="-8.731515458567374" EFFECT_SIZE="5.420000000000002" ESTIMABLE="YES" MEAN_1="65.0" MEAN_2="59.58" ORDER="3031" SD_1="20.26" SD_2="17.24" SE="7.22029362283834" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.05.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Social Functioning</NAME>
<CONT_DATA CI_END="16.83359101497917" CI_START="-11.25359101497917" EFFECT_SIZE="2.789999999999999" ESTIMABLE="YES" MEAN_1="62.16" MEAN_2="59.37" ORDER="3032" SD_1="11.25" SD_2="22.69" SE="7.165229119388531" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.05.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Physical Role Limitations</NAME>
<CONT_DATA CI_END="42.79050833675113" CI_START="-5.310508336751145" EFFECT_SIZE="18.739999999999995" ESTIMABLE="YES" MEAN_1="41.66" MEAN_2="22.92" ORDER="3033" SD_1="27.81" SD_2="34.47" SE="12.270892999289007" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.05.04" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Emotional Role Limitations</NAME>
<CONT_DATA CI_END="55.06971883135756" CI_START="7.650281168642433" EFFECT_SIZE="31.36" ESTIMABLE="YES" MEAN_1="64.41" MEAN_2="33.05" ORDER="3034" SD_1="34.42" SD_2="28.43" SE="12.09701760765851" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.05.05" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>General Mental Health</NAME>
<CONT_DATA CI_END="21.90066150646841" CI_START="1.0393384935315861" EFFECT_SIZE="11.469999999999999" ESTIMABLE="YES" MEAN_1="70.13" MEAN_2="58.66" ORDER="3035" SD_1="16.68" SD_2="10.83" SE="5.321863865226167" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.05.06" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Vitality</NAME>
<CONT_DATA CI_END="16.507103775387463" CI_START="-6.447103775387459" EFFECT_SIZE="5.030000000000001" ESTIMABLE="YES" MEAN_1="65.86" MEAN_2="60.83" ORDER="3036" SD_1="19.9" SD_2="9.73" SE="5.855772792723433" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.05.07" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Bodily Pain</NAME>
<CONT_DATA CI_END="16.417561200145443" CI_START="-5.4375612001454385" EFFECT_SIZE="5.490000000000002" ESTIMABLE="YES" MEAN_1="49.4" MEAN_2="43.91" ORDER="3037" SD_1="13.82" SD_2="14.84" SE="5.575388775681925" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.05.08" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>General Health Perception</NAME>
<CONT_DATA CI_END="16.26064049944897" CI_START="-9.680640499448959" EFFECT_SIZE="3.2900000000000063" ESTIMABLE="YES" MEAN_1="60.2" MEAN_2="56.91" ORDER="3038" SD_1="21.39" SD_2="12.63" SE="6.617795327750776" STUDY_ID="STD-Topuz-2004" TOTAL_1="15" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2008-08-11 12:14:32 -0400" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Conventional TENS (C-TENS) vs Placebo, end of treatment (4 weeks)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2008-06-09 11:43:08 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.014408001618015" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="84" TOTAL_2="83" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Roland Disability Index</NAME>
<GROUP_LABEL_1>C-TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours C-TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.9745046396805137" CI_START="-1.5745046396805116" EFFECT_SIZE="0.20000000000000107" ESTIMABLE="YES" MEAN_1="9.9" MEAN_2="9.7" ORDER="3051" SD_1="5.9" SD_2="5.8" SE="0.9053761465402317" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="84" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.02" MODIFIED="2008-06-09 11:43:14 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.014408001618015" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="84" TOTAL_2="83" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>McGill Work Scale</NAME>
<GROUP_LABEL_1>C-TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours C-TENS</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.0370635475708574" CI_START="-2.437063547570856" EFFECT_SIZE="-0.1999999999999993" ESTIMABLE="YES" MEAN_1="16.6" MEAN_2="16.8" ORDER="3052" SD_1="8.0" SD_2="6.7" SE="1.1413799259662567" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="84" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.03" MODIFIED="2008-08-11 12:14:32 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="50.174832566071665" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="420" TOTAL_2="415" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Physical Measures</NAME>
<GROUP_LABEL_1>C-TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours C-TENS</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="84" TOTAL_2="83" WEIGHT="0.0" Z="0.0">
<NAME>Flexion</NAME>
<CONT_DATA CI_END="3.7545967761672143" CI_START="-7.954596776167217" EFFECT_SIZE="-2.1000000000000014" ESTIMABLE="YES" MEAN_1="57.6" MEAN_2="59.7" ORDER="3053" SD_1="19.6" SD_2="19.0" SE="2.9870940600682094" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="84" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.03.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="84" TOTAL_2="83" WEIGHT="0.0" Z="0.0">
<NAME>Extension</NAME>
<CONT_DATA CI_END="2.2563935188199404" CI_START="-2.056393518819941" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="14.2" MEAN_2="14.1" ORDER="3054" SD_1="7.5" SD_2="6.7" SE="1.1002209917270407" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="84" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.03.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="84" TOTAL_2="83" WEIGHT="0.0" Z="0.0">
<NAME>Straight Leg Raise (Right)</NAME>
<CONT_DATA CI_END="5.292442549272595" CI_START="-4.892442549272589" EFFECT_SIZE="0.20000000000000284" ESTIMABLE="YES" MEAN_1="67.3" MEAN_2="67.1" ORDER="3055" SD_1="18.9" SD_2="14.4" SE="2.5982327172545663" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="84" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.03.04" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="84" TOTAL_2="83" WEIGHT="0.0" Z="0.0">
<NAME>Straight Leg Raise (Left)</NAME>
<CONT_DATA CI_END="7.675562817890811" CI_START="-2.6755628178908113" EFFECT_SIZE="2.5" ESTIMABLE="YES" MEAN_1="68.4" MEAN_2="65.9" ORDER="3056" SD_1="17.8" SD_2="16.3" SE="2.640641796846774" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="84" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.03.05" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="84" TOTAL_2="83" WEIGHT="0.0" Z="0.0">
<NAME>Isolift</NAME>
<CONT_DATA CI_END="21.26435491024779" CI_START="-3.664354910247795" EFFECT_SIZE="8.799999999999997" ESTIMABLE="YES" MEAN_1="52.3" MEAN_2="43.5" ORDER="3057" SD_1="44.6" SD_2="37.3" SE="6.3594816070933105" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="84" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.04" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="84" TOTAL_2="83" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>McGill Activity Scale</NAME>
<GROUP_LABEL_1>C-TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours C-TENS</GRAPH_LABEL_2>
<CONT_DATA CI_END="5.87309385772367" CI_START="-7.2730938577236754" EFFECT_SIZE="-0.7000000000000028" ESTIMABLE="YES" MEAN_1="37.3" MEAN_2="38.0" ORDER="3058" SD_1="22.7" SD_2="20.6" SE="3.3536809398394043" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="84" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2008-07-21 13:02:58 -0400" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Acupuncture-like TENS (A-TENS) vs Placebo, end of treatment (4 weeks)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.01" MODIFIED="2008-06-09 11:43:47 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.014408001618015" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="78" TOTAL_2="83" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Roland Disability Index</NAME>
<GROUP_LABEL_1>A-TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours A-TENS</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.1410651111925154" CI_START="-2.541065111192514" EFFECT_SIZE="-0.6999999999999993" ESTIMABLE="YES" MEAN_1="9.0" MEAN_2="9.7" ORDER="3059" SD_1="6.1" SD_2="5.8" SE="0.9393361948049053" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="78" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.02" MODIFIED="2008-06-09 11:43:55 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.26968653262357" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="78" TOTAL_2="83" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>McGill Work Scale</NAME>
<GROUP_LABEL_1>A-TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours A-TENS</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.1850694812151672" CI_START="-4.185069481215168" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="14.8" MEAN_2="16.8" ORDER="3060" SD_1="7.4" SD_2="6.7" SE="1.1148518536313505" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="78" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.03" MODIFIED="2008-06-09 11:44:10 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="51.03339851969911" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="390" TOTAL_2="415" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Physical Measures</NAME>
<GROUP_LABEL_1>A-TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours A-TENS</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.03.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="83" WEIGHT="0.0" Z="0.0">
<NAME>Flexion</NAME>
<CONT_DATA CI_END="4.046427312984486" CI_START="-7.446427312984492" EFFECT_SIZE="-1.7000000000000028" ESTIMABLE="YES" MEAN_1="58.0" MEAN_2="59.7" ORDER="3061" SD_1="18.2" SD_2="19.0" SE="2.931904544324066" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="78" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.03.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="83" WEIGHT="0.0" Z="0.0">
<NAME>Extension</NAME>
<CONT_DATA CI_END="3.523582447865028" CI_START="-0.523582447865028" EFFECT_SIZE="1.5" ESTIMABLE="YES" MEAN_1="15.6" MEAN_2="14.1" ORDER="3062" SD_1="6.4" SD_2="6.7" SE="1.0324589960972692" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="78" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.03.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="83" WEIGHT="0.0" Z="0.0">
<NAME>Straight Leg Raise (Right)</NAME>
<CONT_DATA CI_END="6.030357413846733" CI_START="-3.6303574138467276" EFFECT_SIZE="1.2000000000000028" ESTIMABLE="YES" MEAN_1="68.3" MEAN_2="67.1" ORDER="3063" SD_1="16.7" SD_2="14.4" SE="2.4645133543003714" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="78" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.03.04" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="83" WEIGHT="0.0" Z="0.0">
<NAME>Straight Leg Raise (Left)</NAME>
<CONT_DATA CI_END="8.702158261594843" CI_START="-1.5021582615948539" EFFECT_SIZE="3.5999999999999943" ESTIMABLE="YES" MEAN_1="69.5" MEAN_2="65.9" ORDER="3064" SD_1="16.7" SD_2="16.3" SE="2.60318980442499" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="78" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.03.05" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="78" TOTAL_2="83" WEIGHT="0.0" Z="0.0">
<NAME>Isolift</NAME>
<CONT_DATA CI_END="31.137909046017825" CI_START="3.4620909539821696" EFFECT_SIZE="17.299999999999997" ESTIMABLE="YES" MEAN_1="60.8" MEAN_2="43.5" ORDER="3065" SD_1="50.8" SD_2="37.3" SE="7.060287410977695" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="78" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.04" MODIFIED="2008-06-09 11:44:16 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="20.629186490770028" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="78" TOTAL_2="83" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>McGill Activity Scale</NAME>
<GROUP_LABEL_1>A-TENS</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours A-TENS</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.111750177459662" CI_START="-11.711750177459656" EFFECT_SIZE="-4.799999999999997" ESTIMABLE="YES" MEAN_1="33.2" MEAN_2="38.0" ORDER="3066" SD_1="23.9" SD_2="20.6" SE="3.526467951441283" STUDY_ID="STD-Jarzem-2005a" TOTAL_1="78" TOTAL_2="83" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2008-08-11 12:05:44 -0400" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2008-08-11 12:05:44 -0400" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Summary of risks of bias</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAbEAAAJfCAIAAAB+FH+JAAAiwUlEQVR42u3dv44USdbG4ZKQEEYb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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2008-08-08 12:09:21 -0400" MODIFIED_BY="[Empty name]">
<FEEDBACK_ITEM ID="FBK-01" MODIFIED="2008-08-08 12:09:17 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-08-08 12:02:00 -0400" MODIFIED_BY="[Empty name]">February 2005 - refer to Milne 2001 review</TITLE>
<DATE_SUBMITTED>
<DATE DAY="" MONTH="" YEAR=""/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2008-08-08 12:09:17 -0400" MODIFIED_BY="[Empty name]">
<P>Review conclusions are sensitive to change:</P>
<P>The main problem with this Cochrane review is that conclusions do not adhere to the limited available data. The review authors state that there is no evidence of effect although 2 out of 3 studies found a significant effect. It must also be mentioned that this review replaces a different review by a previous Cochrane Group (Gadsby and Flowerdew) who reached the opposite conclusion on TENS effectiveness.</P>
<P>The first problem with the current review is that the definitions given for TENS are technically specified, but these specifications are unsupported by evidence and different from the Cochrane-review by Carroll et al. on chronic pain. However, there is evidence that placing electrodes in the same segmental area (dermatome, myotome)and the same side of the body, with frequency range between 1 and 150 Hz and a maximal tolerable stimulation intensity for at least 20 minutes is significantly more effective (32%) than other forms of electrical stimulation (4.2%) for postoperative pain (2003 Eur J Pain, Bjordal JM, Johnson MI, Ljunggren AE). The problem in the review is a that it is very sensitive to changes in interpretation of results the study by Deyo et al. This study is excluded by another Cochrane-review on TENS for Chronic pain because the results could be confounded by co-intervention by exercise therapy in the other Cochrane review of TENS for chronic pain. In addition this study is not performed on non-specific low-back pain, but also includes patients with radicular pain whom are unevenly distributed in the groups. Thirdly Deyo et al. used a too low fixed setting of stimulation intensity at 15 mA(3) for the high frequency (we have checked this with the specifications of the manufacturer). As long as the study from Deyo et al. contributes with 69.5% in the statistical analysis, this has seriously confounded the review results.</P>
<P>In my opinion, the only possible interpretation of the available data is that the limited material provide weak evidence of some effect from TENS for non-specific low-back pain.</P>
<P>1. Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta-analysis with assessment of optimal treatment parameters for postoperative pain. Eur J Pain 2003;7(2):181-8.</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY>
<P>I will forward your comments to our lead author and ask that they be addressed. Since this review is due for updating, I'm sure your comments will be taken under advisement. By the way, you are correct that the results are different from the original review by Gatsby and Flowerdew. Data from another trial of 300+ participants were included in this review, which resulted in different conclusions.</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS>
<P>Jan Magnus Bjordal, Occupational Postdoctoral Research Fellow<BR/>Victoria Pennick, Back Group Co-ordinator</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
<FEEDBACK_ITEM ID="FBK-02" MODIFIED="2008-08-08 12:09:21 -0400" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2008-08-08 12:03:41 -0400" MODIFIED_BY="[Empty name]">August 2005 - refers to Khadilkar 2005 updated review</TITLE>
<DATE_SUBMITTED>
<DATE DAY="" MONTH="" YEAR=""/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2008-08-08 12:09:21 -0400" MODIFIED_BY="[Empty name]">
<P>I observe that the authors have not taken under advisement my comments about the previous review version. The new review conclusion on 'Implications for practice' is in my opinion misleading: 'The evidence from two RCTs (175 patients) provides inconsistent support for the use of TENS as a single treatment modality in the management of chronic LBP.'</P>
<P>This conclusion refers to the negative trial by Deyo et al. and the positive trial by Cheing et al 1999, of which the latter oddly enough was not included in the previous review version from 2001. Only the trial by Cheing et al. 1999 investigated the effect of TENS as a single treatment while the trial by Deyo et al. used a combination of several common interventions. The Deyo trial was performed with too low stimulation intensity for conventional TENS, according to what is known about optimal stimulation intensity (1). TENS was also administered in combination with exercise therapy, daily hot packs and advice to stay active, which are potent and effective interventions for CLBP. Because of these co-interventions, the Deyo trial was excluded from another Cochrane review on TENS for chronic pain.</P>
<P>In the new version, the review authors have limited the diagnostic exclusion criteria for chronic LBP from the previous protocol. The new version criteria for chronic LBP and a more specified location of back pain led to exclusion for heterogeneous populations of three positive trials (Gemignani 1991; Marchand 1993a; Moore 1997).</P>
<P>Regarding the modification of diagnostic criteria, it is interesting to observe that the new diagnostic criteria in this version deviate from the criteria governing the new European guidelines for chronic LBP (www.backpaineurope.org). These guidelines differentiate between non-specific chronic LBP and LBP with nerve root affection, because of differences in their prognosis. From a clinical viewpoint it is also hard to understand why the new review version use an explicit inclusion criteria for trials patients with previous back surgery.</P>
<P>Of the 5 available TENS trials on chronic LBP only the trial by Deyo et al. included patients with a previous history of back pain surgery and nerve root affection (whom were unevenly distributed in the 4 trial groups).</P>
<P>These matters fuel my worries about one vital issue: Was the review protocol truly an a priori protocol, or was it modified later to make the negative trial by Deyo et al. overrule the positive results from the other 4 trials? Although I hope this is not the case, the review authors changed the protocol after they knew the material from the previous version.</P>
<P>In this perspective, where the a priori validity of the review protocol is questioned, what were the clinical considerations behind the new criteria preferences, and why are the new criteria better for answering the most relevant clinical questions about TENS treatment for common CLBP sufferers?</P>
<P>If other related evidence on TENS is considered, the anatomical location should be suitable for TENS treatment as TENS compared to no-treatment control significantly reduced post-operative pain after spinal surgery (2) (n=234), while TENS gave considerable pain relief in acute LBP when compared to sham-TENS (3) (n=72). In other musculoskeletal chronic pain conditions such as knee osteoarthritis, another Cochrane-review have found significant effect from TENS (4).</P>
<P>I do not disagree that large RCTs are needed to confirm the effect of TENS in CLBP, but in my opinion the available data add weak support to a positive effect from TENS in CLBP.</P>
<P>References:</P>
<P>1.Bjordal, J.M., M.I. Johnson, and A.E. Ljunggreen, Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta-analysis with assessment of optimal treatment parameters for postoperative pain. Eur J Pain, 2003. 7(2): p. 181-8.</P>
<P>2.Rainov, N.G., et al., Transcutaneous electrical nerve stimulation(TENS) for acute postoperative pain after spinal surgery. European Journal of Pain, 1994. 15(2): p. 44-49.</P>
<P>3.Bertalanffy, A., et al., Transcutaneous electrical nerve stimulation reduces acute low back pain during emergency transport. Acad Emerg Med, 2005. 12(7): p. 607-11.</P>
<P>4.Osiri, M., et al., Transcutaneous electrical nerve stimulation for knee osteoarthritis. 2001, The Cochrane Library.</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2008-08-08 12:07:27 -0400" MODIFIED_BY="[Empty name]">
<P>On behalf of the authors, Thank you for your ongoing interest in this review. Their comments are below.</P>
<P>The inclusion and exclusion criteria used in the current systematic review represent a synthesis of the selection criteria used by the Philadelphia Panel (2001) for its evidence-based clinical practice guidelines on the management of low back pain and by Milne et al. (2001) for the original version of this Cochrane review [1,2]. Although diagnostic classifications of low-back pain have not been systematically validated [3,4], nonspecific, mechanical low-back pain &#8211; with or without radiating symptoms &#8211; is generally diagnosed by the absence of malignancy, infection, fracture, inflammatory arthritis, cauda equina syndrome and severe or progressive neurological deficit. The methodology of the current review does not specify that patients must have sciatica or a history of previous back surgery to be considered. However, at the same time, these patients were not specifically excluded. According to an international comparison of diagnostic approaches for low-back pain, "all guidelines propose some form of diagnostic triage in which patients are classified as having (1) nonspecific LBP (low-back pain), (2) specific LBP ("red flag" conditions such as tumour, infection, or fracture) and (3) sciatica/radicular syndrome. In some guidelines, sciatica is not considered a separate classification but is variously included for management in the category of nonspecific or specific LBP" [5].</P>
<P>For this update, a newly added criterion required that included studies exhibit relative homogeneity with respect to duration and location of pain. Thus, studies that contained a mixed study population with acute and chronic low-back pain or upper back and lower back pain were excluded. This criterion has been used in previous systematic reviews evaluating the effectiveness of TENS in chronic low-back pain [6, 7]. In addition, a more explicit definition of mechanical low-back pain was provided in the current update, which is consistent with several recent clinical review articles [8,9,10].</P>
<P>Three of the five studies included in the original Cochrane review were excluded because of the additional criteria of homogeneity. Gemigniani et al (1991) examined patients with ankylosing spondylitis, a form of inflammatory arthritis [11]. Marchand et al. (1993) included patients with "more specific pathology" such as ankylosing spondylititis and rheumatoid arthritis [12]. Moore et al. (1997) studied seven patients with pain restricted to the upper or mid back out of a total sample size of 24 [13]. Data for these patients were not reported separately. Finally, the abstract by Jarzem et al (1997), which is still unpublished, was felt to have provided insufficient information and statistical data to permit analysis [14].</P>
<P>The fact that the study by Cheing et al (1999) was missed in the literature search of the original Cochrane review (2001) reflects the possibility that even a systematic search strategy can be imperfect [2,15].</P>
<P>Based on the results of a meta-analysis conducted by Bjordal et al. (2003), the reader states that the stimulation intensities used in the trial by Deyo et al. (1990) were "too low" [6,17]. However, Bjordal et al. (2003) were examining acute, post-operative pain following spinal surgery, which is very different from chronic low-back pain [16]. The optimal stimulation parameters for TENS in chronic low-back pain, including frequency, pulse duration, and intensity, are poorly defined [18,19,20]. A recent RCT comparing the effectiveness of different combinations of stimulation parameters found no significant differences in the reduction of chronic pain [19].</P>
<P>According to the biopsychosocial model, "true multidisciplinary treatment programs have to include medical (pharmacological treatment, education), physical (exercise), vocational and behavioural components and have to be provided by at least by three health care professionals with different clinical backgrounds (physician, physiotherapist, psychologist)" [3]. Based on this definition, the interventions used in the study by Deyo et al (1990) do not qualify as multidisciplinary. In the study, four treatment groups were assigned: (TENS alone), (TENS + exercise), (sham TENS), (exercise + sham TENS) [17]. Since no treatment interaction was found between TENS and exercise, the singular effect of TENS was reported separately, controlling for and independent of any contribution from exercise. It should be noted that heat therapy was provided concurrently to all four treatment groups and, thus, it is unlikely that heat therapy represented a confounding variable [17]. Furthermore, there is as yet no evidence to show that thermotherapy is an effective treatment modality for chronic low-back pain [1,3].</P>
<P>Finally, the authors wish to acknowledge that, in the Deyo trial, patients with previous back surgery were unevenly distributed among the four treatment groups following randomization [17]. However, the numbers of patients with a history of back surgery were not significantly different in the TENS groups compared to the sham-TENS groups that formed the primary comparison [17].</P>
<P>1. Philadelphia Panel. Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for low-back pain. Phys Ther 2001;81(10):1641-74.</P>
<P>2. Milne S, Welch V, Brosseau L, Saginur M, Shea B, Tugwell P, et al. Transcutaneous electrical nerve stimulation (TENS) for chronic low-back pain. In: The Cochrane Database of Systematic Reviews, Issue 2, 2001.</P>
<P>3. COST ACTION B13 Working Group. European Guidelines for the Management of Chronic Non-specific Low Back Pain. June 14th 2005. Available at www.backpaineurope.org. Accessed September 1, 2005.</P>
<P>4. Van Tulder MW, Waddell G. Evidence-based medicine for non-specific low back pain. Best Practice &amp; Research Clinical Rheumatology 2005; 19 (4): vii-ix.</P>
<P>5. Koes BW, van Tulder MW, Ostelo R, Kim Burton A, Waddell G. Clinical Guidelines for the Management of Low Back Pain in Primary Care: An International Comparison. Spine 2001; 26(22): 2504-13.</P>
<P>6. Van Tulder MW, Koes BW, Bart W, Bouter LM. Conservative Treatment of Acute and Chronic Nonspecific Low Back Pain: A systematic review of the most common interventions. Spine 1997: 22(18): 2128-56.</P>
<P>7. Flowerdew MW, Gadsby JG. A review of the treatment of chronic low back pain with acupuncture-like transcutaneous electrical stimulation and transcutaneous electrical nerve stimulation. Complementary Therapies in Medicine 1997;5:193-201.</P>
<P>8. Deyo RA, Weinstein JN. Low back pain. New England Journal of Medicine 2001;344(5):363-70.</P>
<P>9. Carragee EJ, Hannibal M. Diagnostic evaluation of low back pain. Orthopedic Clinics of North America. 2004: 35 (1): 7-16.</P>
<P>10. Harwood MI, Smith BJ. Low back pain: A primary care approach. Clinics in Family Practice. 2005;l7(2): 279-303.</P>
<P>11. Gemigniani G. Transcutaneous Electrical Nerve Stimulation in Ankylosing Spondylitis: A Double-Blind Study. Arth Rheum 1991; 34(6):788-9.</P>
<P>12. Marchand S, Charest J, Li J, Chenard JR, Lavignolle B, Laurencelle L. Is TENS Purely a Placebo Effect? A Controlled Study on Chronic Low Back Pain. Pain 1993; 54(1):99-106.</P>
<P>13. Moore SR, Shurman J. Combined Neuromuscular Electrical Stimulation and Transcutaneous Electrical Nerve Stimulation for Treatment of Chronic Back Pain: A Double-Blind, Repeated Measures Comparison. Arch Phys Med Rehabil 1997; 78:55-60.</P>
<P>14. Jarzem P, Harvey EJ, Arcaro N, Kazarowski J. Transcutaneous Electrical Nerve Stimulation for Non-Acute Low Back Pain: A Randomized Double-Blind Study of Conventional, Nu-Wavefor, Acupuncture-Type and Sham Therapies. In: American Academy of Orthopaedic Surgeons Annual Meeting. 1997.</P>
<P>15. Cheing GL. Hui-Chan CW. Transcutaneous electrical nerve stimulation: nonparallel antinociceptive effects on chronic clinical pain and acute experimental pain. Archives of Physical Medicine &amp; Rehabilitation 1999;80(3):305-12.</P>
<P>16. Bjordal, J.M., M.I. Johnson, and A.E. Ljunggreen, Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta-analysis with assessment of optimal treatment parameters for postoperative pain. Eur J Pain 2003;7(2):181-8.</P>
<P>17. Deyo RA, Walsh NE, Martin DC, Schoenfield LS, Ramamurthy S. A Controlled Trial of Transcutaneous Electrical Stimulation (TENS) and Exercise for Chronic Low Back Pain. New England Journal of Medicine 1990;322(23):1627-34.</P>
<P>18. Belanger AY. Evidence based guide to therapeutic physical agents. Lippincott Williams &amp; Wilkins, 2002.</P>
<P>19. Koke AJA, Schouten JSAG, Lamerichs-Geelen MJH, Lipsch JSM , Waltje EMH, van Kleef M, Patijn J. Pain reducing effect of three types of transcutaneous electrical nerve stimulation in patients with chronic pain: a randomized crossover trial. Pain 2004; 108: 36&#8211;42.</P>
<P>20. Chesterton LS, Barlas P, Foster NE, Lundeberg T, Wright CC, Baxter GD. Sensory stimulation (TENS): effects of parameter manipulation on mechanical pain thresholds in healthy human subjects. Pain 2002;99:253&#8211;62.</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS>
<P>Jan M. Bjordal, Postdoctoral Research Fellow, Institute of Public Health and Primary Health Care, University of Bergen, Norway</P>
<P>Vicki Pennick, Back Review Group Co-ordinator, in consultation with and on behalf of Amole Khadilkar and the review team</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
</FEEDBACK>
<APPENDICES MODIFIED="2008-08-08 12:08:04 -0400" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2008-08-08 12:08:04 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-06-09 11:22:19 -0400" MODIFIED_BY="[Empty name]">Keywords and MeSH terms for initial literature search</TITLE>
<APPENDIX_BODY MODIFIED="2008-08-08 12:08:04 -0400" MODIFIED_BY="[Empty name]">
<P>
<B>TENS:</B>
<BR/>exp electric stimulation therapy/<BR/>((electric$ adj nerve) or therapy).tw.<BR/>electrostimulation.tw.<BR/>electroanalgesia.tw.<BR/>(tens or altens).tw.<BR/>electroacupuncture.tw.<BR/>(high volt or pulsed or current).tw.<BR/>(electromagnetic or electrotherap$).tw.<BR/>
<BR/>
<B>Back pain:</B>
<BR/>exp back/<BR/>exp back injuries/<BR/>exp back pain/<BR/>back.hw,tw.<BR/>(spine or spinal).tw.<BR/>sacrococcygeal.tw.<BR/>lumbar.tw.<BR/>sciatica/ or sciatic$.tw.<BR/>lumbosacral.tw.<BR/>cauda equina.hw,tw.<BR/>backache.tw.</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2008-06-09 11:23:13 -0400" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2008-06-09 11:23:11 -0400" MODIFIED_BY="[Empty name]">MEDLINE search strategy (2004-2007)</TITLE>
<APPENDIX_BODY MODIFIED="2008-06-09 11:23:13 -0400" MODIFIED_BY="[Empty name]">
<P>1 exp "Clinical Trial [Publication Type]"/<BR/>2 randomized.ab,ti.<BR/>3 placebo.ab,ti.<BR/>4 dt.fs.<BR/>5 randomly.ab,ti.<BR/>6 trial.ab,ti.<BR/>7 groups.ab,ti.<BR/>8 or/1-7<BR/>9 Animals/<BR/>10 Humans/<BR/>11 9 not (9 and 10)<BR/>12 8 not 11<BR/>13 dorsalgia.ti,ab.<BR/>14 exp Back Pain/<BR/>15backache.ti,ab.<BR/>16(lumbar adj pain).ti,ab.<BR/>17coccyx.ti,ab.<BR/>18 coccydynia.ti,ab.<BR/>19 sciatica.ti,ab.<BR/>20 sciatica/<BR/>21 spondylosis.ti,ab.<BR/>22 lumbago.ti,ab.<BR/>23 exp Low Back Pain/<BR/>24 low back pain.mp.<BR/>25 or/13-24<BR/>26 Transcutaneous Electric Nerve Stimulation/<BR/>27 TENS.mp.<BR/>28 ALTENS.mp.<BR/>29 transcutaneous nerve stimulation.mp.<BR/>30 TNS.mp.<BR/>31 transcutaneous electrical neurostimulation.mp.<BR/>32 TENMS.mp.<BR/>33 exp Electroacupuncture/<BR/>34 transdermal electrical stimulation.mp.<BR/>35 peripheral conditioning stimulation.mp.<BR/>36 percutaneous neural stimulation.mp.<BR/>37 microamperage electrical stimulation.mp.<BR/>38 cranial electrotherapy stimulation.mp.<BR/>39 transcutaneous cranial electrical stimulation.mp.<BR/>40 transabdominal neurostimulation.mp.<BR/>41 exp Electric Stimulation Therapy/<BR/>42 exp Electric Stimulation/<BR/>43 electroanalgesia.mp.<BR/>44 electrotherapy.mp.<BR/>45 or/26-44<BR/>46 12 and 25 and 45<BR/>47 limit 46 to yr="2004 - 2007"</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>